Podcasts about pharmaceutical

For this episode I am joined by Megan and JC Leston, two parents who are fighting for their son Liam. The oldest of their five children, Liam was born with the rare Cri du Chat or 5p- syndrome. Through years of perseverance, they have created the Cri du Chat Foundation and started a movement to find a cure not only for Liam, but for all families affected by this genetic disease.Listen now to hear their story, and find out more about their work and how you can help at www.criduchatresearch.org.

UK-US agree zero tariffs deal on pharmaceutical products. The agreement means that the NHS will have to pay more for new medicines. We speak to a leading member of pharmaceutical industry. Also: The chairman of the Office for Budget Responsibility resigns after the body mistakenly released its assessment of the budget early. We hear from one MP supportive of the chairman's decision to quit. And Zootropolis, the new Disney animation that is breaking records.

Listen in as our expert panel discusses critical aspects of managing patients on oral cancer therapies. Our experts review tips for optimizing patient care and share best practices for handling these specialized medications.Special guests:Jill Cassaday, BPharm, PharmD, BCPS, BCOPClinical Pharmacist Specialist – Multiple MyelomaBanner MD Anderson Cancer CenterSamuel Snowaert, PharmD, BCOP, MBAClinical Oncology Pharmacist Pharmacists Optimizing Oncology Care Excellence in Michigan (POEM)Covenant Cancer Care CenterLisa Thompson, PharmD, BCOP, CPPSClinical Pharmacy Specialist in Oncology Kaiser Permanente ColoradoYou'll also hear practical advice from TRC's Editorial Advisory Board member:Craig D. Williams, PharmD, FNLA, BCPSClinical Professor of Pharmacy PracticeOregon Health and Science UniversityNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in October 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter, or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources related to this podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Specialty MedsChart: Guide for Helping Patients Afford Their MedicationsChart: Drug Interactions: Cytochrome P450 (CYP), P-glycoprotein, and MoreToolbox: Medication Adherence StrategiesAlgorithm: Redosing Oral Medications After VomitingUse code mt1025 at checkout for 10% off a new or upgraded subscription.Send us a textEmail us: ContactUs@trchealthcare.com. The content of this podcast is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Find the show on YouTube by searching for ‘TRC Healthcare' or clicking here. Learn more about our product offerings at trchealthcare.com.

Chris and Amy Show listeners weigh-in on the debut of sports-betting in Missouri.

Mahdi Sheikh joins Elena Bellafante, Deputy Editor for eClinicalMedicine, to discuss the evidence that regular use of pharmaceutical opioids for pain management may be associated with a higher risk of developing certain cancers, particularly those already known to be linked to opium consumption.Read the full article: https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(25)00371-2/fulltextContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

This is one in a series about possible futures, which will be published in Booch News over the coming weeks. Episode 7 appeared last week. New episodes drop every Friday. Overview Peer-to-peer flavor-sharing platforms enabled home brewers to distribute taste profiles as digital files. Blockchain-verified SCOBY genetics allowed anyone to recreate award-winning kombucha flavors. Traditional beverage companies lost control as open-source fermentation recipes spread globally. This episode follows teenage hacker Luna Reyes as she reverse-engineers Heineken’s proprietary “A-yeast” strain and the century-old master strain used for Budweiser, releasing them under Creative Commons license, triggering a flavor renaissance that made corporate beverages taste like cardboard by comparison. Luna Reyes: The Seventeen-Year-Old Who Liberated Flavor Luna Reyes was brewing kombucha in her Oakland garage when she changed the course of human history. The daughter of Mexican immigrants, she had learned fermentation from her grandmother while teaching herself bioinformatics through YouTube tutorials and volunteering at the Counter Culture Labs Maker Space on Shattuck Avenue. By fifteen, she was running the Bay Area’s most sophisticated home laboratory, utilizing jury-rigged DNA sequencers and microscopes constructed from smartphone cameras. Her breakthrough came in February 2043 while investigating why her kombucha never tasted quite like expensive craft varieties and was different again from her grandmother’s home brew. Using Crispr techniques learned from online forums, Luna began reverse-engineering the microbial genetics of premium alcoholic beverages. Her target wasn’t kombucha—it was the closely guarded yeast strains that gave corporate beers their distinctive flavors. Luna hunched over her microscope, examining bacterial cultures from her latest kombucha batch. Around her, salvaged DNA sequencers hummed, fermentation vessels bubbled, and computer screens displayed multi-hued patterns of genetic sequences. Her grandmother, Rosa, entered carrying a tray with three glasses of homemade kombucha. “Mija, you’ve been working for six hours straight. Drink something.” Luna accepted the glass without looking up. “Abuela, your kombucha tastes better than anything I can buy in stores and the ones I’ve experimented with. Why? I’m using the same base ingredients—tea, sugar, water—but mine never has this complexity.” Her grandmother laughed. “Because I’ve been feeding this SCOBY for forty years. It knows what to do. You can’t rush relationships.” Luna’s sister Maya, lounging against a workbench, waved her phone. “Luna, people have noticed your forum post about Health-Ade’s fermentation process. Someone says you’re wasting your time trying to replicate commercial kombuchas.” “I’m not trying to replicate them,” Luna said, finally looking up. “I’m trying to understand why their kombucha tastes different than that I make at home. It’s not the ingredients. It’s not the process. It’s the microbial genetics.” Rosa sat down beside her granddaughter. “When I was young in Oaxaca, every family had their own kombucha culture, passed down generation to generation. Each tasted different because the bacteria adapted to their environment, their ingredients, their care. We had a saying, Hay tantas fermentaciones en el mundo como estrellas en el cielo nocturno – there are as many ferments in the world as stars in the night sky. The big companies want every bottle to be identical. That kills what makes fermentation special.” “Exactly!” Luna pulled up genetic sequences on her screen. “I’ve been reverse-engineering samples from different commercial kombuchas. Health-Ade, GT’s, Brew Dr—they all have consistent microbial profiles.” The Great Heist: Cracking Corporate DNA Luna’s first major hack targeted Heineken’s legendary “A-yeast” strain, developed in 1886 by Dr. Hartog Elion—a student of renowned chemist Louis Pasteur—in the company’s Amsterdam laboratory and protected by over 150 years of trade secret law. Using samples obtained from discarded brewery waste (technically legal under the “garbage doctrine”), she spent six months mapping the strain’s complete genetic sequence in her makeshift lab. The breakthrough required extraordinary ingenuity. Luna couldn’t afford professional gene sequencers, so she modified a broken Illumina iSeq100 purchased on eBay for $200. Her sequencing runs took weeks rather than hours; her results were identical to those produced by million-dollar laboratory equipment. Her detailed laboratory notebooks, later published as The Garage Genomics Manifesto, became essential reading for the biotech hacker movement. The Budweiser project proved even more challenging. Anheuser-Busch’s century-old master strain had been protected by layers of corporate secrecy rivaling classified military programs. The company maintained multiple backup cultures in cryogenic facilities across three continents, never allowing complete genetic mapping by outside researchers. Luna’s success required infiltrating the company’s waste-disposal systems at four breweries, collecting samples over 18 months while evading corporate security. The Decision The night before Luna was scheduled to meet her fellow bio-hackers at Oakland’s Counter Culture Labs, she sat at her workstation, hesitant, wondering if she was doing the right thing. Her sister Maya came in, looking worried. “Luna, I found something you need to see,” she says. “Remember Marcus Park? He tried releasing proprietary yeast information in 2039. Heineken buried him. He lost everything. His daughter dropped out of college. His wife left him. He’s working at a gas station now.” Luna spent the night researching what happened to Park. She found that almost everyone who challenged corporate IP ended up on the losing side of the law. It was not pretty. In the morning, Abuela Rosa finds her crying in her room. “Mija, what’s wrong?” she asks. “Oh, Abuela,” Luna says between sobs. “What am I doing? What if I’m wrong? What if I destroy our family? What if this ruins Mom and Dad? What if I’m just being selfish?” “That’s the fear talking.” Her grandmother reassured her. “Fear is wisdom warning you to be careful. But fear can also be a cage.” That evening at the Counter Culture Labs, Luna assembled a small group of advisors. She needed their guidance. She had the completed genetic sequences for Heineken A-yeast and Budweiser’s master strain on her laptop, ready for release. But is this the time and place to release them to the world? Dr. Marcus Webb, a bioinformatics researcher in his forties and Luna’s mentor, examined her sequencing data. “This is solid work, Luna. Your jury-rigged equipment is crude. The results are accurate. You’ve fully mapped both strains.” “The question isn’t whether I can do it,” Luna said. “It’s whether I should let the world know I did it.” On screen, Cory Doctorow, the author and digital rights activist, leaned forward. “Let’s be clear about what you’re proposing. You’d be releasing genetic information that corporations have protected as trade secrets for over a century. They’ll argue you stole their intellectual property. You’ll face lawsuits, possibly criminal charges.” “Is it their property?” Luna challenged. “These are naturally occurring organisms. They didn’t create that yeast. Evolution did. They just happened to be there when it appeared. That does not make it theirs any more than finding a wildflower means they own the species. Can you really own something that existed before you found it?” Doctorow, the Electronic Frontier Foundation representative spoke up. “There’s legal precedent both ways. Diamond v. Chakrabarty established that genetically modified organisms can be patented. But naturally occurring genetic sequences? That’s murky. The companies will argue that their decades of cultivation and protection created protectable trade secrets.” “Trade secrets require keeping information secret,” Luna argued. “They throw this yeast away constantly. If they’re not protecting it, how can they claim trade secret status?” Dr. Webb cautioned, “Luna, even if you’re legally in the right—which is debatable—you’re seventeen years old. You’ll be fighting multinational corporations with unlimited legal resources. They’ll bury you in litigation for years.” “That’s where we come in,” Doctorow said. “The EFF can provide legal defense. Creative Commons can help structure the license. You need to understand: this will consume your life. College, career plans, normal teenage experiences—all on hold while you fight this battle.” Luna was quiet for a moment, then pulled up a photo on her laptop: her grandmother Rosa, teaching her to ferment at age seven. “My abuela says fermentation is about sharing and passing living cultures between generations. Corporations have turned it into intellectual property to be protected and controlled. If I can break that control—even a little—isn’t that worth fighting for?” Maya spoke up from the back. “Luna, I love you, but you’re being naive. They won’t just sue you. They’ll make an example of you. Your face on every news channel, portrayed as a thief, a criminal. Our family harassed. Your future destroyed. For what? So people can brew beer with the same yeast as Heineken?” “Not just beer,” Luna responded passionately. “This is about whether living organisms can be owned. Whether genetic information—the code of life itself—can be locked behind intellectual property law. Yes, it starts with beer yeast. But what about beneficial bacteria? Life-saving microorganisms? Medicine-producing fungi? Where does it end?” Dr. Webb nodded slowly. “She’s right. This is bigger than beer. As biotech advances, genetic control becomes power over life itself. Do we want corporations owning that?” Doctorow sighed. “If you do this, Luna, do it right. Release everything simultaneously—BitTorrent, WikiLeaks, Creative Commons servers, distributed networks worldwide. Make it impossible to contain. Include complete cultivation protocols so anyone can reproduce your results. Make the data so damn widely available that suppressing it becomes futile.” “And write a manifesto,” he added. “Explain why you’re doing this. Frame the issue. Make it about principles, not piracy.” Luna nodded, fingers already typing. “When should I release?” “Pick a date with symbolic meaning,” Dr. Webb suggested. “Make it an event, not just a data dump.” Luna smiled. “December 15. The Bill of Rights Day. Appropriate for declaring biological rights, don’t you think?” Maya groaned. “You’re really doing this, aren’t you?” “Yes. I’m really doing this.” The Creative Commons Liberation On Tuesday, December 15, 2043—a date now celebrated as “Open Flavor Day”—Luna released the genetic sequences on multiple open-source networks. Her manifesto, titled Your Grandmother’s Yeast Is Your Birthright, argued that microbial genetics belonged to humanity’s shared heritage rather than corporate shareholders. It stated: Commercial companies have protected yeast strains for over a century. They’ve used intellectual property law to control flavor itself. But genetic information isn’t like a recipe or a formula—it’s biological code that evolved over millions of years before humans ever cultivated it. These strains are protected as trade secrets—the bacteria don’t belong to anyone. They existed before Heineken, before Budweiser, before trademark law. The companies just happened to isolate and cultivate them. Her data packages included DNA sequences and complete protocols for cultivating, modifying, and improving the strains. Luna’s releases came with user-friendly software that allowed amateur brewers to simulate genetic modifications before attempting them in real fermentations. Within 24 hours, over ten thousand people worldwide downloaded the files. The Creative Commons community erupted in celebration. Cory Doctorow’s blog post, The Teenager Who Stole Christmas (From Corporate Beer), went viral within hours. The Electronic Frontier Foundation immediately offered Luna legal protection, while the Free Software Foundation created the “Luna Defense Fund” to support her anticipated legal battles. The Legal Assault Heineken’s response was swift. The company filed emergency injunctions in 12 countries simultaneously, seeking to prevent the distribution of its “stolen intellectual property.” Their legal team, led by former U.S. Attorney General William Barr III, demanded Luna’s immediate arrest for “economic terrorism” and “theft of trade secrets valued at over $50 billion.” Anheuser-Busch’s reaction was even more extreme. CEO Marcel Telles IV appeared on CNBC, calling Luna “a bioterrorist who threatens the foundation of American capitalism.” The company hired private investigators to surveil Luna’s family and offered a $10 million reward for information leading to her prosecution. Their legal filing compared Luna’s actions to “stealing the formula for Coca-Cola and publishing it in the New York Times.” In Heineken’s Amsterdam headquarters, executives convened an emergency meeting. “Who is Luna Reyes?” the CEO demanded. The legal counsel pulled up information. “She’s a seventeen-year-old high school student in Oakland, California. No criminal record. Volunteers at a maker space. Has been posting about fermentation on various forums for years.” “A child released our proprietary yeast strain to the world, and we didn’t know she was even working on this?” The CEO’s face reddened. “How do we contain it?” “We can’t. It’s distributed across thousands of servers in dozens of countries with different IP laws. We can sue Reyes, but the information is out there permanently.” An executive interjected, “What about the other breweries? Will they join our lawsuit?” “Some are considering it. Others…” The counsel paused. “Others are quietly downloading the sequences themselves. They see an opportunity to break our market dominance.” “She obtained samples from our waste disposal,” another executive explained. “Technically legal under the garbage doctrine. The sequencing itself isn’t illegal. The release under Creative Commons…” “Is theft!” the CEO shouted. “File emergency injunctions. Twelve countries. Get her arrested for economic terrorism.” Similar scenes played out at Anheuser-Busch headquarters in St. Louis. CEO Telles addressed his team: “This is bioterrorism. She’s destroyed intellectual property worth billions. I want her prosecuted to the fullest extent of the law. Hire private investigators. Find everything about her and her family. Make her life hell!” By noon, both companies had filed lawsuits. By evening, Fox News was running stories about the “teenage bioterrorist” who “stole American corporate secrets.” Back in Oakland, Luna’s phone rang constantly. Her parents discovered what she’d done. Her mother cried. Her father was furious and terrified. Friends called with either congratulations or warnings. She was convinced that private investigators were photographing their house. Maya suspected she was followed to work. On Wednesday morning, Dr. Webb calls: “Luna, they’re offering me $2 million to testify against you. They’re going after everyone in your network.” Luna has a sickening feeling that she’s put everyone at risk. By Thursday, she is considering taking it all back somehow, sending an apology to the corporations, anything to protect her family. Luna turned off her phone and sat with her grandmother. “It’s started,” Luna said quietly. “Sí, mija. You’ve declared war. Now we see if you can survive it.” Maya burst in, laptop in hand. “Luna, you need to see this. The downloads aren’t slowing—they’re accelerating. Every time Heineken or Budweiser shuts down a website, ten mirror sites appear. People are treating this like a digital freedom fight. You’ve become a symbol.” Luna pulled up her own screen. The #FreeLuna hashtag was trending. Crowdfunding campaigns for her legal defense had raised $400,000 in twelve hours. Academic institutions were publicly endorsing her release, calling it “essential scientific information.” “They’re trying to destroy you,” Maya said, “but they’re making you famous instead.” Rosa handed Luna a fresh kombucha. “This is what happens when you fight for what’s right, mija. Sometimes the world surprises you by supporting you.” Luna’s Fame The corporations’ attempts to suppress Luna’s releases had the opposite effect. Every cease-and-desist letter generated thousands of new downloads. The genetic data became impossible to contain once the academic community embraced Luna’s work. Dr. Jennifer Doudna, the legendary Crispr pioneer now in her eighties, publicly endorsed Luna’s releases in a Science magazine editorial: Ms. Reyes has liberated essential scientific information that corporations held hostage for commercial gain. Genetic sequences from naturally occurring organisms should not be locked behind intellectual property law. They belong to humanity’s knowledge commons. While corporations claim Luna stole trade secrets, I argue she freed biological knowledge that was never theirs to own. There are no trade secrets in biology—only knowledge temporarily hidden from the commons. This is civil disobedience of the highest order—breaking unjust laws to advance human freedom. Ms. Reyes didn’t steal; she liberated. MIT’s biology department invited Luna to lecture, while Harvard offered her a full scholarship despite her lack of a high school diploma. The legal battles consumed corporate resources while generating negative publicity. Heineken’s stock price dropped 34% as consumers organized boycotts in support of Luna’s “yeast liberation.” Beer sales plummeted as customers waited for home-brewed alternatives using Luna’s open-source genetics. The Flavor Renaissance Luna’s releases triggered an explosion of creativity that corporate R&D departments had never imagined. Within six months, amateur brewers worldwide were producing thousands of flavor variations impossible under corporate constraints. The open-source model enabled rapid iteration and global collaboration, rendering traditional brewing companies obsolete. The world was engaged. In some of the most unlikely places. In Evanston, Illinois, a group of former seminary students who discovered fermentation during a silent retreat, transformed Gregorian chants into microbial devotionals. Tenor Marcus Webb (Dr. Webb’s nephew) realized symbiosis mirrored vocal harmony—multiple voices creating something greater than their parts. “In honoring the mystery of fermentation we express our love of the Creator,” he said. Here's ‘Consortium Vocalis' honoring the mother SCOBY. [Chorus]Our SCOBYIs pureOur SCOBYIs strongOur SCOBYKnows no boundariesOur SCOBYStrengthens as it fermentsOur SCOBYIs bacteria and yeast Our SCOBYTurns sucrose into glucose and fructoseIt ferments these simple sugars into ethanol and carbon dioxide,Acetic acid bacteria oxidize much of that ethanol into organic acidsSuch as acetic, gluconic, and other acids.This steadily lowers the pHMaking the tea taste sour-tangy instead of purely sweet. [Chorus] Our SCOBYThen helps microbes produce acids, enzymes, and small amounts of B‑vitaminsWhile probiotics grow in the liquid.The pH falls to help inhibit unwanted microbesOur SCOBY creates a self-preserving, acidic environment in the tea [Chorus] In Kingston, Jamaica, Rastafarian’s combined an award-winning kombucha sequenced in Humboldt County, California, with locally grown ganja into a sacramental beverage to help open their mind to reasoning and focus on Jah. Once fermented, it was consumed over the course of a three-day Nyabinghi ceremony. “Luna Reyes is truly blessed. She strengthened our unity as a people, and our Rastafari’ booch help us chant down Babylon,” a Rasta man smiled, blowing smoke from a spliff the size of his arm. The Groundation Collective’s reggae anthem ‘Oh Luna’ joyfully celebrated Luna Reyes’ pioneering discovery. Oh Luna, Oh Luna, Oh Luna ReyesI love the sound of your nameYou so deserve your fame Luna, Luna, Oh Luna ReyesShining brightYou warm my heart Luna, Luna, Oh Luna ReyesYou cracked the codeTeenage prophet, fermentation queenSymbiosis roadA genius at seventeen Oh Luna, Luna, Luna ReyesBeautiful moonMakes me swoon Oh Luna, Luna, Luna ReyesFreedom to fermentYou are heaven sentTo save us Luna, Luna, Oh Luna ReyesYou opened the doorTo so much moreKombucha tastes so goodLike it should Oh Luna, Oh Luna, Oh LunaI love you, love you, love youOh Luna, Luna, LunaLove you, love you,Love Luna, Luna love. In São Paulo, Brazil, MAPA-certified Brazilian kombucha brands combined Heineken and cacao-fermenting yeasts with cupuaçu from indigenous Amazonian peoples, to create the chocolate-flavored ‘booch that won Gold at the 20th World Kombucha Awards. A cervejeiro explained to reporters: “Luna Reyes gave us the foundation. We added local innovation. This is what happens when you democratize biology.” The Brazilian singer Dandara Sereia covered ‘Our Fermented Future’—The Hollow Pines tune destined to become a hit at the 2053 Washington DC Fermentation Festival. Baby sit a little closer, sip some ‘booch with meI brewed this batch with the SCOBY my grandma gave to me.On the back porch swing at twilight, watching fireflies danceYour hand in mine, kombucha fine, the sweetest sweet romance. They say that wine and roses are the way to win the heartBut your kombucha warmed me right up from the start.Fermentation makes the heart grow fonder, truer words they ain’t been saidYour SCOBY’s got a place forever — in my heart, and in my bed. Let’s share our SCOBYs, baby, merge our ferments into oneLike cultures in a crock jar dancing, underneath the sun.The tang of your Lactobacillus is exactly what I’m missingYour Brettanomyces bacteria got this country girl reminiscing. Oh yeah, let’s share those SCOBYs, baby, merge our ferments into oneYour yeasts and my bacteria working till the magic’s doneYou’ve got the acetic acid honey, I’ve got the patience and the timeLet’s bubble up together, let our cultures intertwine. I’ve got that symbiotic feeling, something wild and something trueYour SCOBY’s in my heart, right there next to youThe way your Acetobacter turns sugar into goldIs how you turned my lonely life into a hand to hold. We’ve got the acetic acid and the glucuronic tooWe’ve got that symbiotic feeling, so righteous and so trueOne sip of your sweet ‘booch, Lord, and you had me from the start,It’s our fermented future, that no-one can tear apart. It’s our fermented future…It’s our fermented future…It’s our fermented future… “Luna Variants”—strains derived from her releases—began winning international brewing competitions, embarrassing corporate entries with their complexity and innovation. Traditional beer flavors seemed flat and artificial compared to the genetic symphonies created by collaborative open-source development. Despite the outpouring of positive vibes, the corporations spared no expense to hold Luna to account in the courts. The Preliminary Hearing A preliminary hearing was held in the United States District Court for the Northern District of California on June 14, 2044. Luna sat at the defendant’s table, her hands folded so tightly her knuckles had gone white. She wore a borrowed blazer—too big in the shoulders—over a white button-down shirt Maya had ironed that morning. At seventeen, she looked even younger under the courtroom’s fluorescent lights. Across the aisle, Heineken’s legal team occupied three tables. Fifteen attorneys in matching navy suits shuffled documents and whispered into phones. Their lead counsel, William Barr III, wore gold cufflinks that caught the light when he gestured. Luna recognized him from the news—the former Attorney General, now commanding $2,000 an hour to destroy people like her. Her own legal representation consisted of two people: Rose Kennerson from the Electronic Frontier Foundation, a public interest lawyer who’d flown in from DC on a red-eye, and Dr. Marcus Webb, technically a witness but sitting beside Luna because she’d asked him to. Behind them, the gallery was packed. Luna’s parents sat in the second row, her father’s face gray, her mother clutching a rosary. Maya had taken the day off work. Abuela Rosa sat in the front row directly behind Luna, her ancient SCOBY wrapped in silk in her lap, as if its presence might protect her granddaughter. Judge Catherine Ironwood entered—sixty-ish, steel-gray hair pulled back severely, known for pro-corporate rulings. She’d been a pharmaceutical industry lawyer for twenty years before her appointment. “All rise,” the bailiff called. Judge Ironwood settled into her chair and surveyed the courtroom with the expression of someone who’d already decided the outcome and resented having to perform the formalities. “We’re here for a preliminary injunction hearing in Heineken International B.V. versus Luna Marie Reyes.” She looked directly at Luna. “Ms. Reyes, you’re seventeen years old?” Luna stood, hesitant. “Yes, your honor.” “Where are your parents?” “Here, your honor.” Luna’s mother half-rose, then sat back down. “Ms. Kennerson, your client is a minor. Are the parents aware they could be held liable for damages?” Rose Kennerson stood smoothly. “Yes, your honor. The Reyes family has been fully advised of the legal implications.” Luna glanced back. Her father’s jaw was clenched so tight she could see the muscles working. He wouldn’t meet her eyes. “Very well. Mr. Barr, you may proceed.” Barr rose like a battleship emerging from fog—massive, expensive, inevitable. He buttoned his suit jacket and approached the bench without notes. “Your honor, this is the simplest case I’ve argued in thirty years. The defendant admits to obtaining my client’s proprietary biological materials. She admits to sequencing their genetic information. She admits to distributing that information globally, in deliberate violation of trade secret protections that have existed for over 150 years. She did this knowingly, systematically, and with the explicit intent to destroy my client’s competitive advantage.” Luna felt Sarah’s hand on her arm—stay calm. Barr continued. “Heineken International has invested over $200 million in the development, cultivation, and protection of the A-yeast strain. Then this teenager”—he pointed at Luna—”obtained samples from our waste disposal systems, reverse-engineered our genetic sequences, and released them to the world via BitTorrent, deliberately placing them beyond retrieval.” He paced now, warming to his theme. “The damage is incalculable. We estimate lost market value at $50 billion. But it’s not just about money. The defendant has destroyed the possibility of competition in the brewing industry. When everyone has access to the same genetic materials, there’s no innovation, no differentiation, no reason for consumers to choose one product over another. She has, in effect, communized an entire industry.” Luna couldn’t help herself. “That’s not—” Sarah grabbed her wrist. “Don’t.” Judge Ironwood’s eyes narrowed. “Ms. Reyes, you will have your opportunity to speak. Until then, you will remain silent, or I will have you removed from this courtroom. Do you understand?” “Yes, your honor.” Luna’s voice came out smaller than she intended. Barr smiled slightly. “Your honor, the relief we seek is straightforward. We ask this court to order the defendant to provide us with a complete list of all servers, websites, and distribution networks where the stolen genetic data currently resides. We ask that she be ordered to cooperate fully in suppressing the data. We ask that she be enjoined from any further distribution. And we ask that she be ordered to pay compensatory damages of $5 billion, plus punitive damages to be determined at trial.” He returned to his seat. One of his associate attorneys handed him a bottle of Pellegrino. He took a sip and waited. Judge Ironwood looked at Sarah. “Ms. Kennerson?” Sarah stood. She looked tiny compared to Barr—five-foot-three, maybe 110 pounds, wearing a suit from Target. But when she spoke, her voice filled the courtroom. “Your honor, Mr. Barr has given you a compelling story about a corporation that’s been wronged. But it’s not the right story. The right story is about whether naturally occurring organisms—creatures that evolved over millions of years, long before humans ever existed—can be owned by a corporation simply because that corporation happened to isolate them.” She walked toward the bench. “Let’s be clear about what the A-yeast strain is. It’s not a genetically modified organism. It’s not a patented invention. It’s a naturally occurring yeast. Heineken didn’t create it. Evolution created it. Heineken merely found it. And for 158 years, they’ve claimed that finding something gives them the right to prevent anyone else from studying it, understanding it, or using it.” Barr was on his feet. “Objection, your honor. This is a preliminary hearing about injunctive relief, not a philosophical debate about intellectual property theory.” “Sustained. Ms. Kennerson, please focus on the specific legal issues before this court.” “Your honor, the specific legal issue is whether naturally occurring genetic sequences constitute protectable trade secrets. My client contends they do not. She obtained the yeast samples from Heineken’s waste disposal—materials they had discarded. Under the garbage doctrine, she had every right to analyze those materials. The genetic sequences she discovered are factual information about naturally occurring organisms. You cannot trade-secret facts about nature.” Luna watched Judge Ironwood’s face. Nothing. No reaction. Sarah pressed on. “Mr. Barr claims my client ‘stole’ genetic information worth $5 billion. But information cannot be stolen—it can only be shared. When I tell you a fact, I don’t lose possession of that fact. We both have it. That’s how knowledge works. Heineken hasn’t lost their yeast. They still have it. They can still brew with it. What they’ve lost is their monopoly on that knowledge. And monopolies on facts about nature should never have existed in the first place.” “Your honor—” Barr tried to interrupt. Judge Ironwood waved him down. “Continue, Ms. Kennerson.” “Your honor, Heineken wants this court to order a seventeen-year-old girl to somehow suppress information that has already been distributed to over 100,000 people in 147 countries. That’s impossible. You can’t unring a bell. You can’t put knowledge back in a bottle. Even if this court ordered my client to provide a list of servers—which she shouldn’t have to do—that list would be incomplete within hours as new mirror sites appeared. The information is out. The only question is whether we punish my client for sharing factual information about naturally occurring organisms.” She turned to face Luna’s family. “Ms. Reyes taught herself bioinformatics from YouTube videos. She works at home with equipment she bought on eBay. She has no criminal record. She’s never been in trouble. She saw a question that interested her—why do commercial beers taste like they do?—and she pursued that question with the tools available to her. When she discovered the answer, she shared it with the world, under a Creative Commons license that specifically protects sharing for educational and scientific purposes. If that’s terrorism, your honor, then every scientist who’s ever published a research paper is a terrorist.” Sarah sat down. Luna wanted to hug her. Judge Ironwood leaned back. “Ms. Reyes, stand up.” Luna rose, her legs shaking. “Do you understand the seriousness of these proceedings?” “Yes, your honor.” “Do you understand that Heineken International is asking me to hold you in contempt of court if you refuse to help them suppress the information you released?” “Yes, your honor.” “Do you understand that contempt of court could result in your detention in a juvenile facility until you reach the age of eighteen, and potentially longer if the contempt continues?” Luna’s mother gasped audibly. Her father put his arm around her. “Yes, your honor,” Luna said, though her voice wavered. “Then let me ask you directly: If I order you to provide Heineken with a complete list of all locations where the genetic data you released currently resides, will you comply?” The courtroom went silent. Luna could hear her own heartbeat. Sarah started to stand—”Your honor, I advise my client not to answer—” “Sit down, Ms. Kennerson. I’m asking your client a direct question. She can choose to answer or not.” Judge Ironwood’s eyes never left Luna. “Well, Ms. Reyes? Will you comply with a court order to help Heineken suppress the information you released?” Luna looked at her parents. Her mother was crying silently. Her father’s face was stone. She looked at Abuela Rosa. Her grandmother nodded once—tell the truth. Luna looked back at the judge. “No, your honor.” Barr shot to his feet. “Your honor, the defendant has just admitted she intends to defy a court order—” “I heard her, Mr. Barr.” Judge Ironwood’s voice was ice. “Ms. Reyes, do you understand you’ve just told a federal judge you will refuse a direct order?” “Yes, your honor.” “And you’re still refusing?” “Yes, your honor.” “Why?” Sarah stood quickly. “Your honor, my client doesn’t have to explain—” “I want to hear it.” Judge Ironwood leaned forward. “Ms. Reyes, tell me why you would risk jail rather than help undo what you’ve done.” Luna took a breath. Her whole body was shaking, but her voice was steady. “Because it would be wrong, your honor.” “Wrong how?” “The genetic sequences I released evolved over millions of years. Heineken didn’t create that yeast. They isolated one strain and claimed ownership of it. The code of life belongs to everyone. That’s humanity’s heritage. Even if you send me to jail, I can’t help suppress the truth.” Judge Ironwood stared at her for a long moment. “That’s a very pretty speech, Ms. Reyes. But this court operates under the law, not your personal philosophy about what should or shouldn’t be owned. Trade secret law exists. Heineken’s rights exist. And you violated those rights.” Luna did not hesitate. “With respect, your honor, I don’t think those rights should exist.” Barr exploded. “Your honor, this is outrageous! The defendant is openly stating she believes she has the right to violate any law she disagrees with—” “That’s not what I said.” Luna’s fear was transforming into something else—something harder. “I’m saying that some laws are unjust. And when laws are unjust, civil disobedience becomes necessary. People broke unjust laws during the civil rights movement. People broke unjust laws when they helped slaves escape. The constitution says members of the military do not have to obey illegal orders, despite what those in power might claim. Sometimes the law is wrong. And when the law says corporations can own genetic information about naturally occurring organisms, the law is wrong.” Judge Ironwood’s face flushed. “Ms. Reyes, you are not Rosa Parks. This is not the civil rights movement. This is a case about intellectual property theft.” “It’s a case about whether life can be property, your honor.” “Enough.” Judge Ironwood slammed her gavel. “Ms. Kennerson, control your client.” Sarah pulled Luna back into her chair. “Luna, stop talking,” she hissed. Judge Ironwood shuffled papers, visibly trying to compose herself. “I’m taking a fifteen-minute recess to consider the injunction request. We’ll reconvene at 11:30. Ms. Reyes, I strongly suggest you use this time to reconsider your position.” The gavel fell again, and Judge Ironwood swept out. The hallway outside the courtroom erupted. Reporters swarmed. Luna’s father grabbed her arm and pulled her into a witness room. Her mother followed, still crying. Maya slipped in before Sarah closed the door. “What were you thinking?” Luna’s father’s voice shook. “You just told a federal judge you’ll defy her orders. They’re going to put you in jail, Luna. Do you understand that? Jail!” “Ricardo, please—” Her mother tried to calm him. “No, Elena. Our daughter just committed contempt of court in front of fifty witnesses. They’re going to take her from us.” He turned to Luna, his eyes wet. “Why? Why couldn’t you just apologize? Say you made a mistake? We could have ended this.” “Because I didn’t make a mistake, Papa.” “You destroyed their property!” “It wasn’t their property. It was never their property.” “The law says it was!” “Then the law is wrong!” Her father stepped back as if she’d slapped him. “Do you know what your mother and I have sacrificed to keep you out of trouble? Do you know how hard we’ve worked since we came to this country to give you opportunities we never had? And you throw it away for yeast. Not for justice. Not for people. For yeast.” Luna’s eyes filled with tears. “It’s not about yeast, Papa. It’s about whether corporations get to own life. If Heineken can own yeast, why not bacteria? Why not human genes? Where does it stop?” “It stops when my daughter goes to jail!” He was shouting now. “I don’t care about Heineken. I don’t care about yeast. I care about you. And you just told that judge you’ll defy her. She’s going to put you in jail, and there’s nothing I can do to stop it.” “Ricardo, por favor—” Elena put her hand on his arm. He shook it off. “No. She needs to hear this. Luna, if you go to jail, your life is over. No college will accept you. No company will hire you. You’ll have a criminal record. You’ll be marked forever. Is that what you want?” “I want to do what’s right.” “What’s right is protecting your family! What’s right is not destroying your future for a principle!” he said. Luna responded, “What’s right is not letting corporations own the code of life!”They stared at each other. Maya spoke up quietly from the corner. “Papa, she can’t back down now. The whole world is watching.” “Let the world watch someone else!” Ricardo turned on Maya. “You encourage this. You film her, you post her manifestos online, you help her become famous. You’re her sister. You’re supposed to protect her, not help her destroy herself.” “I am protecting her,” Maya said. “I’m protecting her from becoming someone who backs down when the world tells her she’s wrong, even though she knows she’s right.” Ricardo looked between his daughters. “Ambos están locos! You’re both insane.” Abuela Rosa opened the door and entered. She’d been listening from the hallway. “Ricardo, enough.” “Mama, stay out of this.” “No.” Rosa moved between Ricardo and Luna. “You’re afraid. I understand. But fear makes you cruel, mijo. Your daughter is brave. She’s doing something important. And you’re making her choose between you and what’s right. Don’t do that.” “She’s seventeen years old! She’s a child!” “She’s old enough to know right from wrong.” Rosa put her hand on Ricardo’s cheek. “When I was sixteen, I left Oaxaca with nothing but the clothes on my back and this SCOBY. Everyone said I was crazy. Your father said I would fail. But I knew I had to go, even if it cost me everything. Sometimes our children have to do things that terrify us. That’s how the world changes.” Ricardo pulled away. “If they put her in jail, will that change the world, Mama? When she’s sitting in a cell while Heineken continues doing whatever they want, will that have been worth it?” “Yes,” Luna said quietly. “Even if I go to jail, yes. Because thousands of people now have the genetic sequences, Heineken can’t put that back. They can punish me, but they can’t undo what I did. The information is free. It’s going to stay free. And if the price of that is me going to jail, then that’s the price.” Her father looked at her as if seeing her for the first time. “I don’t know who you are anymore.” “I’m still your daughter, Papa. I’m just also someone who won’t let corporations own life.” A knock on the door. Sarah poked her head in. “They’re reconvening. Luna, we need to go.” Back in the courtroom, the atmosphere had shifted. The gallery was more crowded—word had spread during the recess. Luna recognized several people from online forums. Some held signs reading “FREE LUNA” and “GENETICS BELONG TO EVERYONE.” Judge Ironwood entered and sat without ceremony. “I’ve reviewed the submissions and heard the arguments. This is my ruling.” Luna’s hand found Maya’s in the row behind her. Squeezed tight. “The question before this court is whether to grant Heineken International’s motion for a preliminary injunction requiring Ms. Reyes to assist in suppressing the genetic information she released. To grant such an injunction, Heineken must demonstrate four things: likelihood of success on the merits, likelihood of irreparable harm without the injunction, balance of equities in their favor, and that an injunction serves the public interest.” Barr was nodding. These were his arguments. “Having considered the evidence and the applicable law, I find that Heineken has demonstrated likelihood of success on the merits. Trade secret law clearly protects proprietary business information, and the A-yeast strain appears to meet the legal definition of a trade secret.” Luna’s stomach dropped. “However, I also find that Heineken has failed to demonstrate that a preliminary injunction would effectively prevent the irreparable harm they claim. Ms. Kennerson is correct that the genetic information has already been distributed to over 100,000 people worldwide. Ordering one teenager to provide a list of servers would be, in technical terms, pointless. New copies would appear faster than they could be suppressed.” Barr’s face tightened. “Furthermore, I find that the balance of equities does not favor Heineken. They ask this court to potentially incarcerate a seventeen-year-old girl for refusing to suppress information that is, by her account, factual data about naturally occurring organisms. The potential harm to Ms. Reyes—including detention, criminal record, and foreclosure of educational and career opportunities—substantially outweighs any additional harm Heineken might suffer from continued distribution of information that is already widely distributed.” Luna felt Maya’s grip tighten. Was this good? This sounded good. “Finally, and most importantly, I find that granting this injunction would not serve the public interest. The court takes judicial notice that this case has generated substantial public debate about the scope of intellectual property protection in biotechnology. The questions raised by Ms. Reyes—whether naturally occurring genetic sequences should be ownable, whether facts about nature can be trade secrets, whether knowledge can be property—are questions that deserve answers from a higher authority than this court. These are questions for appellate courts, perhaps ultimately for the Supreme Court. And they are questions best answered in the context of a full trial on the merits, not in an emergency injunction hearing.” Barr was on his feet. “Your honor—” “Sit down, Mr. Barr. I’m not finished.” He sat, his face purple. “Therefore, Heineken International’s motion for preliminary injunction is denied. Ms. Reyes will not be required to assist in suppressing the genetic information she released. However,”—Judge Ironwood looked directly at Luna—”this ruling should not be construed as approval of Ms. Reyes’ actions. Heineken’s claims for damages and other relief remain viable and will proceed to trial. Ms. Reyes, you may have won this battle, but this war is far from over. Anything you want to say?” Luna stood slowly. “Your honor, I just want to say… thank you. For letting this go to trial. For letting these questions be answered properly. That’s all I ever wanted—for someone to seriously consider whether corporations should be allowed to own genetic information about naturally occurring organisms. So thank you.” Judge Ironwood’s expression softened slightly. “Ms. Reyes, I hope you’re prepared for what comes next. Heineken has unlimited resources. They will pursue this case for years if necessary. You’ll be in litigation until you’re twenty-five years old. Your entire young adulthood will be consumed by depositions, court appearances, and legal fees. Are you prepared for that?” “Yes, your honor.” “Why?” Luna glanced at her grandmother, who nodded. “Because some questions are worth answering, your honor. Even if it takes years. Even if it costs everything. The question of whether corporations can own life—that’s worth answering. And if I have to spend my twenties answering it, then that’s what I’ll do.” Judge Ironwood studied her for a long moment. “You remind me of someone I used to know. Someone who believed the law should serve justice, not just power.” She paused. “That person doesn’t exist anymore. The law ground her down. I hope it doesn’t do the same to you.” She raised her gavel. “This hearing is adjourned. The parties will be notified of the trial date once it’s scheduled. Ms. Reyes, good luck. I think you’re going to need it.” The gavel fell. Outside the courthouse, the scene was chaotic. News cameras surrounded Luna. Reporters shouted questions. But Luna barely heard them. She was looking at her father, who stood apart from the crowd, watching her. She walked over to him. “Papa, I’m sorry I yelled.” He didn’t speak for a moment. Then he pulled her into a hug so tight it hurt. “Don’t apologize for being brave,” he whispered into her hair. “I’m just afraid of losing you.” “You won’t lose me, Papa. I promise.” “You can’t promise that. Not anymore.” He pulled back, holding her shoulders. “But I’m proud of you. I’m terrified, but I’m proud.” Her mother joined them, tears streaming down her face. “No more court. Please, no more court.” “I can’t promise that either, Mama.” Elena touched Luna’s face. “Then promise me you’ll be careful. Promise me you’ll remember that you’re not just fighting for genetics. You’re fighting for your life.” Luna smiled. “I promise.” Abuela Rosa appeared, carrying her SCOBY. “Come, mija. We should go before the reporters follow us home.” As they pushed through the crowd toward Maya’s car, Luna's phone buzzed continuously. Text messages and emails pouring in. But what caught her attention was a text from Dr. Webb: You were right. I’m sorry I doubted. Check your email—Dr. Doudna wants to talk. Luna opened her email. The subject line made her stop walking: From: jennifer.doudna@berkeley.eduSubject: Civil Disobedience of the Highest Order She started to read: Dear Ms. Reyes, I watched your hearing this morning. What you did in that courtroom—refusing to back down even when threatened with jail—was one of the bravest things I’ve seen in forty years of science. You’re not just fighting for yeast genetics. You’re fighting for the principle that knowledge about nature belongs to humanity, not to corporations. I want to help… Luna looked up at her family—her father’s worried face, her mother’s tears, Maya’s proud smile, Abuela Rosa’s serene confidence. Behind them, the courthouse where she’d nearly been sent to jail. Around them, reporters and cameras and strangers who’d traveled across the country to support her. She thought about Judge Ironwood’s warning: This war is far from over. She thought about Barr’s face when the injunction was denied. She thought about the thousands who’d downloaded the genetic sequences and were, right now, brewing with genetics that had been locked away for 158 years. Worth it. All of it. Even the fear. Maya opened the car door. “Come on, little revolutionary. Let’s go home.” The Corporate Surrender By 2045, both Heineken and Anheuser-Busch quietly dropped their lawsuits against Luna. Their legal costs had exceeded $200 million while accomplishing nothing except generating bad publicity. More importantly, their “protected” strains had become worthless in a market flooded with superior alternatives. Heineken’s CEO attempted to salvage the company by embracing open-source brewing. His announcement that Heineken would “join the La Luna Revolution” was met with skepticism from the brewing community, which recalled the company’s aggressive legal tactics. The craft brewing community’s response was hostile. “They spent two years trying to destroy her,” a prominent brewmaster told The New Brewer Magazine. “Now they want credit for ’embracing’ the revolution she forced on them? Heineken didn’t join the Luna Revolution—they surrendered to it. There’s a difference.” The global brands never recovered their market share. Luna’s Transformation Luna’s success transformed her from a garage tinkerer into a global icon of the open knowledge movement. Her 2046 TED Talk, “Why Flavor Belongs to Everyone,” went viral. She argued that corporate control over living organisms represented “biological colonialism” that impoverished human culture by restricting natural diversity. Rather than commercializing her fame, Luna founded the Global Fermentation Commons, a nonprofit organization dedicated to preserving and sharing microbial genetics worldwide. Their laboratories operated as open-access research facilities where anyone could experiment with biological systems. The headquarters of the Global Fermentation Commons occupied a former Genentech facility donated by Dr. Webb. Six continents, forty researchers, one mission: preserve and share microbial genetics worldwide. Luna addressed a crowded auditorium at the organization’s third anniversary. “When I released Heineken and Budweiser’s yeast strains, some people called it theft. Others called it liberation. I called it returning biological knowledge to the commons, where it belongs. Three years later, so-called Luna Variants have created economic opportunities for thousands of small brewers, improved food security in developing regions, and demonstrated that genetic freedom drives innovation faster than corporate control.” She continued. “We’re not stopping with beer. The same principles apply to all fermentation: cheese cultures, yogurt bacteria, koji fungi, sourdough starters. Every traditionally fermented food relies on microorganisms that corporations increasingly claim to own. We’re systematically liberating them.” A World Health Organization representative raised a concern: “Ms. Reyes, while we support democratizing food fermentation, there are legitimate concerns about pharmaceutical applications. What prevents someone from using your open-source genetics to create dangerous organisms?” Luna nodded. “Fair question. First, the organisms we release are food-safe cultures with centuries of safe use. Second, dangerous genetic modifications require sophisticated laboratory equipment and expertise—far beyond what releasing genetic sequences enables. Third, determined bad actors already have access to dangerous biology, enabled by AI. We’re not creating new risks; we’re democratizing beneficial biology.” “Pharmaceutical companies argue you’re undermining their investments in beneficial organisms,” another representative pressed. “Pharmaceutical companies invest in modifying organisms,” Luna clarified. “Those modifications can be patented. What we oppose is claiming ownership over naturally occurring organisms or their baseline genetics. If you genetically engineer a bacterium to produce insulin, patent your engineering. Don’t claim ownership over the bacterial species itself.” A Monsanto representative stood. “Your organization recently cracked and released our proprietary seed genetics. That’s direct theft of our property.” Luna didn’t flinch. “Seeds that farmers cultivated for thousands of years before Monsanto existed? You didn’t invent corn, wheat, or soybeans. You modified them. Your modifications may be protectable; the baseline genetics are humanity’s heritage. We’re liberating what should never have been owned.” “The ‘Luna Legion’ has cost us hundreds of millions!” the representative protested. “Good,” Luna responded calmly. “You’ve cost farmers their sovereignty for decades. Consider it karma.” After the presentation, Dr. Doudna approached Luna privately. “You’ve accomplished something remarkable,” the elderly scientist said. “When I developed Crispr, I never imagined a teenager would use similar principles to challenge corporate biology. You’re forcing conversations about genetic ownership that we’ve avoided for decades.” “It needed forcing,” Luna replied. “Corporations were quietly owning life itself, one patent at a time. Someone had to say no.” “The pharmaceutical industry is terrified of you,” Doudna continued. “They see what happened to brewing and imagine the same for their carefully controlled bacterial strains. You’re going to face even more aggressive opposition.” “I know. Once people understand that biological knowledge can be liberated, they start questioning all biological ownership. We’re not stopping.” The New Economy of Taste Following Luna’s breakthrough, peer-to-peer flavor-sharing platforms emerged as the dominant force in food culture. The “FlavorChain” blockchain allowed brewers to track genetic lineages while ensuring proper attribution to original creators. SCOBY lineages were carefully sequenced, catalogued, and registered on global blockchain ledgers. Each award-winning kombucha strain carried a “genetic passport”—its microbial makeup, the unique balance of yeasts and bacteria that gave rise to particular mouthfeel, fizz, and flavor spectrum, was mapped, hashed, and permanently recorded. Brewers who created a new flavor could claim authorship, just as musicians once copyrighted songs. No matter how many times a SCOBY was divided, its fingerprint could be verified. Fermentation Guilds formed to share recipes through FlavorChain, enabling decentralized digital markets like SymbioTrdr, built on trust and transparency rather than speculation. They allowed people to interact and transact on a global, permissionless, self-executing platform. Within days, a SCOBY strain from the Himalayas could appear in a brew in Buenos Aires, its journey traced through open ledgers showing who tended, adapted, and shared it. Kombucha recipes were no longer jealously guarded secrets. They were open to anyone who wanted to brew. With a few clicks, a Guild member in Nairobi could download the blockchain-verified SCOBY genome that had won Gold at the Tokyo Fermentation Festival. Local biotech printers—as common in 2100 kitchens as microwave ovens had once been—could reconstitute the living culture cell by cell. Children began inheriting SCOBY lineages the way earlier generations inherited family names. Weddings combined SCOBY cultures as symbolic unions. (Let’s share our SCOBYs, baby, merge our ferments into one.) When someone died, their SCOBY was divided among friends and family—a continuation of essence through taste. Kombucha was no longer merely consumed; it was communed with. This transparency transformed kombucha from a minority regional curiosity into a universal language. A festival in Brazil might feature ten local interpretations of the same “Golden SCOBY” strain—one brewed with passionfruit, another with cupuaçu, a third with açaí berries. The core microbial signature remained intact, while the terroir of fruit and spice gave each version a unique accent. Brewers didn’t lose their craft—they gained a canvas. Award-winning SCOBYs were the foundations on which endless new flavor experiments flourished. Many people were now as prolific as William Esslinger, the founder of St Louis’s Confluence Kombucha, who was renowned for developing 800 flavors in the 2020s. Code of Symbiosis The Symbiosis Code, ratified at the first World Fermentation Gathering in Reykjavik (2063), bound Fermentation Guilds to three principles: Transparency — All microbial knowledge is to be shared freely. Reciprocity — No brew should be produced without acknowledging the source. Community — Every fermentation must nourish more than the brewer. This code replaced corporate law. It was enforced by reputation, not by governments. A Guild member who betrayed the code found their SCOBYs mysteriously refusing to thrive—a poetic justice the biologists never quite explained. Every Guild had elders—called Mothers of the Jar or Keepers of the Yeast. They carried living SCOBYs wrapped in silk pouches when traveling, exchanging fragments as blessings. These elders became moral anchors of the age, counselors and mediators trusted more than politicians. When disputes arose—over territory, resources, or ethics—brewers, not lawyers, met to share a round of Truth Brew, a ferment so balanced that it was said to reveal dishonesty through bitterness. The Fullness of Time The International Biotech Conference of 2052 invited Luna to give the closing keynote—a controversial decision that prompted several corporate sponsors to withdraw support. The auditorium was packed with supporters, critics, and the merely curious. “Nine years ago, I released genetic sequences for beer yeast strains protected as trade secrets. I was called a thief, a bioterrorist, worse. Today, I want to discuss what we’ve learned from those years of open-source biology.” She displayed a chart showing the explosion of brewing innovation since 2043. “In the traditional corporate model, a few companies control a few strains, producing a limited variety. With the open-source model, thousands of brewers using thousands of variants, producing infinite diversity. As Duff McDonald wrote “Anything that alive contains the universe, or infinite possibility. Kombucha is infinite possibility in a drink.” And the results speak for themselves—flavor innovation accelerated a thousand-fold when we removed corporate control.” A student activist approached the microphone. “Ms. Reyes, you’ve inspired movements to liberate seed genetics, soil bacteria, and traditional medicine cultures. The ‘Luna Legion’ is spreading globally. What’s your message to young people who want to continue this work?” Luna smiled. “First, understand the risks. I was sued by multinational corporations, received death threats, spent years fighting legal battles. This work has costs. Second, be strategic. Release information you’ve generated yourself through legal methods—no hacking, no theft. Third, build communities. I survived because people supported me—legally, financially, emotionally. You can’t fight corporations alone. Finally, remember why you’re doing it: to return biological knowledge to the commons where it belongs. That purpose will sustain you through the hard parts.” Teaching By twenty-eight, Luna was a MacArthur Fellow, teaching fermentation workshops in a converted Anheuser-Busch facility. As she watched her students—former corporate employees learning to think like ecosystems rather than factories—she reflected that her teenage hack had accomplished more than liberating yeast genetics. She had helped humanity remember that flavor, like knowledge, grows stronger when shared rather than hoarded. Luna’s garage had evolved into a sophisticated community biolab. The original jury-rigged equipment had been replaced with professional gear funded by her MacArthur Fellowship. Abuela Rosa still maintained her fermentation crocks in the corner—a reminder of where everything started. A group of five

What really happens to medicines after we swallow them? Where do they end up… and what exactly are we flushing away? Which medicines might we be taking —unknowingly—the next time we pour a glass of tap water?In this episode, we explore the hidden life of pharmaceuticals after they leave our bodies. Professor Alistair Boxall, environmental chemist at the University of York, joins us to unpack the real impact of medicines on our rivers and waterways.We delve into the risks these drugs pose to ecosystems, the surprising range of pharmaceuticals now detected in UK rivers, and the solutions that could help protect both wildlife and human health.It's a fascinating journey—from the pharmacy to the sewer pipe, and into the natural world. A story of unintended consequences… and why they matter.Relevant resources we discuss:-Pharmaceutical Pollution of the English National Parkshttps://onlinelibrary.wiley.com/doi/10.1002/etc.5973-Pharmaceutical wastewater as Emerging Contaminants (EC): Treatment technologies, impact on environment and human health https://doi.org/10.1016/j.nexus.2022.100076-Streams of medicines: what's hiding in the UK's waterways? The Guardian: Science Weekly  podcast https://www.theguardian.com/science/audio/2025/apr/08/streams-of-medicines-whats-hiding-in-the-uks-waterways-podcastAs with all of our guests, Alistair shares with us his Memory Evoking Medicine, a career anthem and book that has influenced his life.From Prescription to Ocean — A TEDx Talk by Jamie Hayes. We're incredibly proud to share that Aural Apothecary co-host Jamie Hayes has taken to the TEDx stage with a thought-provoking talk:  Prescription to Ocean: The Hidden Impact of Medicines https://www.youtube.com/watch?v=swCLNaAG5qYJamie explores a fascinating and urgent question: What happens to our medicines once they leave the prescription pad — and how do they impact the world beyond the patient? It's a journey that connects healthcare, the environment, and our shared responsibility for the future. You'll never think about prescribing (or taking) medicines in quite the same way again.Please take a few minutes to watch, reflect, and share — this is a conversation worth having.Please follow us on LinkedIn! Let us know what you think of the show. https://www.linkedin.com/company/auralapothecary/You can listen to the Aural Apothecary playlist here; https://open.spotify.com/playlist/3OsWj4w8sxsvuwR9zMXgn5?si=tiHXrQI7QsGtSQwPyz1KBg You can view the Aural Apothecary Library here;  https://litalist.com/shelf/view-bookcase?publicId=KN6E3OOur website is https://www.theauralapothecary.com/To get in touch follow us on LinkedIn, Bluesky and X @auralapothecary or email us at auralapothecarypod@gmail.com.Don't forget to rate us and comment wherever you have got this podcast from.

Stephen Grootes speaks to Peter Wharton-Hood, CEO at Life Healthcare Group, about the company taking a hit after selling business to an American pharmaceutical giant. However, the group reported a strong trading performance, achieving overall revenue growth of between 5.5% and 6.5%. The Money Show is a podcast hosted by well-known journalist and radio presenter, Stephen Grootes. He explores the latest economic trends, business developments, investment opportunities, and personal finance strategies. Each episode features engaging conversations with top newsmakers, industry experts, financial advisors, entrepreneurs, and politicians, offering you thought-provoking insights to navigate the ever-changing financial landscape.    Thank you for listening to a podcast from The Money Show Listen live Primedia+ weekdays from 18:00 and 20:00 (SA Time) to The Money Show with Stephen Grootes broadcast on 702 https://buff.ly/gk3y0Kj and CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/7QpH0jY or find all the catch-up podcasts here https://buff.ly/PlhvUVe Subscribe to The Money Show Daily Newsletter and the Weekly Business Wrap here https://buff.ly/v5mfetc The Money Show is brought to you by Absa     Follow us on social media   702 on Facebook: https://www.facebook.com/TalkRadio702 702 on TikTok: https://www.tiktok.com/@talkradio702 702 on Instagram: https://www.instagram.com/talkradio702/ 702 on X: https://x.com/CapeTalk 702 on YouTube: https://www.youtube.com/@radio702   CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/Radio702 CapeTalk on YouTube: https://www.youtube.com/@See omnystudio.com/listener for privacy information.

About Ariel Garten:Ariel Garten is a visionary neuroscientist, entrepreneur, and thought leader best known as the co-founder and chief evangelist of Muse, the brain-sensing headband that makes meditation easier through real-time neurofeedback. With a foundation in neuroscience from the University of Toronto, Ariel's early research at the Krembil Neuroscience Centre focused on Parkinson's disease and hippocampal neurogenesis. Her work bridges science, art, and mental wellness, a fusion evident in Muse's elegant design and its mission to help users strengthen their minds through technology.Before founding InteraXon, the parent company of Muse, in 2009, Ariel worked as a therapist in private practice, helping clients uncover clarity and overcome self-limiting beliefs. Her interest in brain-computer interfaces began in 2003 in Dr. Steve Mann's lab, where she explored thought-controlled technologies—an experience that later inspired InteraXon's debut project, Bright Ideas, which allowed participants at the 2010 Winter Olympics to control the lights on the CN Tower and Niagara Falls with their minds.Things You'll Learn:Daily brain tracking gives individuals and clinicians the kind of insights previously only available in labs, making brain health far more accessible.MUSE's new AI sleep coach and Digital Sleeping Pill adjust audio in real time to help users fall asleep faster and return to sleep when they wake.The device's dual EEG and fNIRS sensors measure electrical activity and blood oxygenation, enabling both sleep analysis and cognitive training.Research from the Mayo Clinic indicates that just five minutes of daily use resulted in a 54% reduction in burnout among healthcare professionals.Pharmaceutical companies, clinicians, and researchers are turning to MUSE for distributed sleep studies, cognitive data, and medication response tracking.Resources:Connect with and follow Ariel Garten on LinkedIn.Follow MUSE on LinkedIn and visit their website.Email the MUSE team directly here.

Today, we're diving into a topic that sounds like science fiction but is rapidly becoming a reality: the ethics of "engineered attraction." This field encompasses biotechnological and pharmaceutical interventions designed to influence human romantic and social appeal, and it's sparking intense ethical debates.Become a supporter of this podcast: https://www.spreaker.com/podcast/lets-talk-sex--5052038/support.

過去一年，你有沒有也覺得自己被各種 AI 相關內容鋪天蓋地地轟炸？從遇到疑難雜症請它幫忙搜尋、整理資料、處理公事，到純粹當成娛樂、請它生成各種有趣圖片，AI 的應用就像當年的網路搜尋一樣，幾乎無所不在地滲入我們的生活。 這集的三腳貓實驗室裡，在日常工作與生活中頻繁使用 AI 的「一般用戶」浩文和天豪，以及在生醫產業中運用 AI 參與藥物研究，並時刻關注AI前沿發展進程的「高階玩家」Mike，一起來聊聊現在 AI 在生醫學者日常中的各種使用場景，還有目前在大眾應用層面上的發展與限制。 我們或許已經習慣打開 AI 工具的網頁，在介面裡點選、輸入、獲得服務，就像多年前逐漸習慣使用 Google 一樣。但我們準備好迎接下一個階段了嗎？一個可以自己設計、客製化各種 Agent，自動幫你處理需求的時代？面對功能愈來愈強大的 AI 工具，你是否也開始擔心，身為「人」在科學研究中的角色，會不會很快被取代？歡迎你來聽聽這一集，和我們一起思考、一起面對這個正洶湧而來的新時代。 相關連結 如何使用AI工具提升科學研究生產力: Dr. Candice Chu's talk https://www.youtube.com/watch?v=CTTESpCK4yc https://www.nature.com/articles/d41586-024-03775-7 Chain of thought prompting: https://www.prompthub.us/blog/chain-of-thought-prompting-guide https://research.google/blog/accelerating-scientific-breakthroughs-with-an-ai-co-scientist/ 工作人員 內容製作：MIke、浩文、天豪 後製：天豪 文案：天豪 音樂：雯薇 封面：雯薇 上架：天豪 宣傳：Angel、雯薇 -- Hosting provided by SoundOn

Learn how Vyvanse works differently from other ADHD medications and whether it could help your teenager with focus, impulse control, and anxiety. Experts break down the benefits, side effects, dosing, and why pairing medication with therapy matters most.Visit https://missionprephealthcare.com/mental-health-resources/stimulants/vyvanse/ Mission Prep City: San Juan Capistrano Address: 30310 Rancho Viejo Rd. Website: https://missionprephealthcare.com/

In this podcast, Edmund Shing (Global Chief Investment Officer) dicusses how investors' over-optimism has begun to cool, leading to a shift toward others sectors.Following the strong momentum led by technology stocks in the US and in Asia, concerns rose over the elevated valuations that tech stocks had reached.Over the last week, a mini correction was seen, sending among others bitcoin down by 29% and tech giant Oracle by 34% from its September highs. This setback of global and US stocks should not worry investors as the Nasdaq 100 index has merely returned to the level it had reached in early October.However, while more speculative names and the tech sector stumble, other sectors are taking over leadership of the global stock market. Pharmaceutical & biotech sectors are lately outperforming the Nasdaq Index. Another more surprising outperforming industry in November is Oil & Gas.We maintain our positive 12-month view on global stocks and would suggest that now is a good time to look at sectors and stocks displaying relative strength outside of technology.Hosted by Ausha. See ausha.co/privacy-policy for more information.

A West Pharmaceutical é uma das empresas mais importantes da indústria bio farmacêutica — mas quase ninguém a conhece. Neste episódio, Igor Vieira e Pamela Macedo exploram como esta empresa norte americana se tornou essencial para a segurança e eficácia dos medicamentos injetáveis por todo o mundo.Este podcast tem um carácter informativo e educativo, não representa uma recomendação de investimento.Disponível no nosso canal do Youtube e Spotify.Assista a todos os episódios do Investidor Inteligente em https://www.casadeinvestimentos.pt/podcast#CasadeInvestimentos #OInvestidorInteligente  #WestPharma

Why have we lost our trust in natural medicine? In this video, we'll discuss why natural medicine is ignored and sometimes even dismissed as folklore. Is it wise to invalidate the wisdom of the past? Discover the truth about natural medicine in this video.0:00 Introduction: Natural medicine suppression0:19 United States Dispensatory 0:38 Pharmaceutical vs. natural medicine 3:08 The advancement of medicine 6:35 Natural remedies of the past The “United States Dispensatory” by Wood and Lawall may provide insight into alternative medicine censorship in the United States. The 21st edition, published in 1926, was the most authoritative and comprehensive reference for American medicine. At the time of publication, 75% of medicine consisted of various natural remedies, while only 25% consisted of synthetic compounds.Since then, there's been a gradual transition from natural remedies to synthetic drugs. When the 22nd edition of the book was published in 1943, the ratio of natural to synthetic drugs shifted to 50:50.Today, medicine is often prescribed without considering lifestyle, eating habits, sleep patterns, stress levels, or the microbiome. Symptoms of the underlying problems are treated without addressing the root cause.Discover these 20 natural remedies that have stood the test of time, along with the ailment they have historically been used to address.1. Cod liver oil—Tuberculosis, tetany, nerve pain2. Nutmeg oil—Psychotic problems3. Olive oil—Mild laxative, gallstones 4. Pine needle oil—Eliminates mucus from the lungs 5. Castor oil—Mild laxative 6. Sandalwood oil—Gonorrhea, bronchitis, bladder infections 7. Sassafras oil—Antiseptic 8. Betaine hydrochloride—Indigestion, gastric problems9. Pepsin—Digestive issues 10. Lugol's iodine—Thyroid support and protection 11. Magnesium sulfate—Sleep support, anxiety, pain killer 12. Calcium chloride—Acidifies the body 13. Liver extract—Anemia 14. Methylene blue—Shrinks tumors, meningitis, bladder infections, gonorrhea, and supports the mitochondria15. Lithium carbonate—Relaxation, anxiety, and depression relief16. Glauber's salt—Laxative17. Vitamin D—Autoimmune conditions18. Colloidal silver19. Activated charcoal—Food poisoning, gas20. Niacin—Lowers triglycerides, increases HDL, increases lifespan, supports cardiovascular health, acts as a NAD precursorDr. Eric Berg DC Bio:Dr. Berg, age 60, is a chiropractor who specializes in Healthy Ketosis & Intermittent Fasting. He is the Director of Dr. Berg Nutritionals and author of the best-selling book The Healthy Keto Plan. He no longer practices, but focuses on health education through social media.Disclaimer: Dr. Eric Berg received his Doctor of Chiropractic degree from Palmer College of Chiropractic in 1988. His use of “doctor” or “Dr.” in relation to himself solely refers to that degree. Dr. Berg is a licensed chiropractor in Virginia, California, and Louisiana, but he no longer practices chiropractic in any state and does not see patients, so he can focus on educating people as a full-time activity, yet he maintains an active license. This video is for general informational purposes only. It should not be used to self-diagnose, and it is not a substitute for a medical exam, cure, treatment, diagnosis, prescription, or recommendation. It does not create a doctor-patient relationship between Dr. Berg and you. You should not make any change in your health regimen or diet before first consulting a physician and obtaining a medical exam, diagnosis, and recommendation. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition.

Did you happen to notice that Tylenol recently launched a dietary supplement product range designed to promote joint comfort and mobility? When the best-selling pain relief brand in the U.S. market launches a drug-free product range…it not only speaks volumes about shifting consumer attitudes from treatment to prevention, but also about the increasing importance of supplements for the pharmaceutical industry. And maybe unsurprisingly to my fellow industry nerds, but this new product launch further strengthens the pharma-nutra convergence trend. In fact, pharmaceutical companies have been increasingly tapping into the preventive segment…seeking new revenue opportunities to mitigate against numerous factors hampering industry profits. Therefore, even during periods of relatively strong demand for OTC drugs, supplements still present an important opportunity to expand the product offering…thus we expect this trend to continue and likely permanently reshape the nutraceutical industry.

As AI promises to accelerate drug development, a critical question emerges: can pharmaceutical manufacturing keep pace? In this episode, Martin Wood and Adrian La Porta examine how artificial intelligence could transform the entire pharmaceutical value chain, from quality control paradigms to facility design.Recorded as a preview to Bryden Wood's Accelerate Pharmaceuticals event on 25th November, the discussion explores fundamental questions about the future of drug manufacturing. Adrian argues that current quality systems are essentially compensations for our limited understanding of manufacturing processes - and that AI could enable a complete reversal of this paradigm through real-time, data-driven quality monitoring.The conversation ranges from the potential for patient data feedback loops that could reshape manufacturing in near real-time, to whether facilities should be designed around autonomous systems rather than people. They examine why continuous manufacturing has struggled to gain traction, whether digital twins could eliminate traditional scale-up challenges, and how distributed manufacturing models might reshape global supply chains.A thought-provoking exploration of whether AI can finally bridge the longstanding gap between drug development innovation and manufacturing industrialisation - and what it will take to get there.Send us a textTo learn more about Bryden Wood's Design to Value philosophy, visit www.brydenwood.com. You can also follow Bryden Wood on LinkedIn.

“VO2 max is the best predictor of lifespan,” says Peter Attia, M.D. Peter Attia, M.D., physician, founder of Early Medical, and expert in the applied science of longevity, joins us today to break down the key levers for extending both lifespan and healthspan—from how to train for a higher VO2 max to the biomarkers that truly predict long-term health. - The most powerful habit for longevity (~6:15) - VO2 max (~8:55) - How to increase your VO2 max (~10:08) - Heart rate vs. perceived exertion (~12:35) - Attia's strength training routine (~15:20) - 2 exercises Attia stopped doing (17:00) - Diminishing returns in terms of exercise (~19:55) - His take on wearables (~21:25) - Cardiovascular disease markers (~23:38) - Lowering ApoB (~25:35) - Pharmaceutical interventions for LDL & ApoB (~27:50) - Neuroinflammation markers (~37:25) - Perspectives on statins (~40:45) - The role of nutrition (~42:50) - Potential benefits of GLP-1s (~45:00) - Peptides (~47:50) - The power of exercise (~51:00) Referenced in the episode:  - Follow Attia on Instagram (@peterattiamd) - Listen to his podcast, The Peter Attia Drive  - Check out his website (https://peterattiamd.com/)  - Pick up his book, Outlive: The Science of Art & Longevity  - Take his class on MasterClass (https://www.masterclass.com/series/science-for-a-longer-better-life) - Watch the trailer for his class on MasterClass (youtube.com/watch?v=f_Mz095swls&feature=youtu.be)   We hope you enjoy this episode, and feel free to watch the full video on YouTube! Whether it's an article or podcast, we want to know what we can do to help here at mindbodygreen. Let us know at: podcast@mindbodygreen.com. Learn more about your ad choices. Visit megaphone.fm/adchoices

Finding good staff in your medical practice seems only to be getting more challenging. At the same time, more tools that substitute for in-office staff are available. Those tools should be helping, but sometimes they seem to make things more confusing. My guest today runs a medical virtual assistant company. They help their clients deal with staffing shortages and make sense of their choices to fill them. She'll share her insights with us.Beth Lachance is leading Global Medical in vision and the day-to-day business operations securing the functionality of the business to drive extensive and sustainable growth. Combining her strong leadership and determination with over 22 years of corporate experience in the private and public sector of Surgical Device, Pharmaceutical, and Specialty Pharmacy Industries – she keeps the company moving forward with high-level strategy while understanding the details of day-to-day execution to ensure steadfast success.In this episode Carl White and Beth LaChance discuss:Changes in staffing landscape since our last podcast episode in 2022Projections for the future of staff availabilityUses of medical virtual assistantsAI and virtual assistants – are they competitors or collaborators?Want to be a guest on PracticeCare®?Have an experience with a business issue you think others will benefit from? Come on PracticeCare® and tell the world! Here's the link where you can get the process started.Connect with Beth LaChancewww.facebook.com/globalmedicalvawww.instagram.com/globalmedicalvaswww.linkedin.com/company/globalmedicalva www.youtube.com/@globalmedicalvirtualassistantsConnect with Carl WhiteWebsite: http://www.marketvisorygroup.comEmail:  whitec@marketvisorygroup.comFacebook:  https://www.facebook.com/marketvisorygroupYouTube: https://www.youtube.com/channel/UCD9BLCu_i2ezBj1ktUHVmigLinkedIn: http://www.linkedin.com/in/healthcaremktg

ඕස්ට්‍රේලියානු ෆෙඩරල් රජය ඖෂධ ප්‍රතිලාභ යෝජනා ක්‍රමයට නිදන්ගත වකුගඩු රෝග සඳහා ලබාදෙන ඖෂධයක් එකතු කරන බව නිවේදනය කළා. Jardiance නැතහොත් එම්පැග්ලිෆ්ලොසින් ලෙසද හැඳින්වෙන මෙම ඖෂධය BSP පහසුකම වෙත ඇතුලත් කිරීමෙන් 65,000 කට වැඩි ඕස්ට්‍රේලියානුවන් පිරිසකට ප්‍රතිලාභ ලබනු ඇතැයි අපේක්ෂා කෙරේ. අද කාලීන විග්‍රහයෙන් විමසා බැලෙන්නේ මේ පිළිබඳවයි.

In this conversation, Dr. Nathan Bryan discusses the critical role of nitric oxide in human health, its production, and the factors that can lead to its deficiency. He explains how nitric oxide functions as a signaling molecule, its importance in cardiovascular health, athletic performance, and immune function, and the misconceptions surrounding nitric oxide supplements. The discussion also covers the impact of diet, oral hygiene, and lifestyle choices on nitric oxide levels, as well as practical biohacks to enhance its production. Dr. Bryan emphasizes the need for restorative physiology in health management and the potential of nitric oxide in future medical therapies.Dr. Nathan S. Bryan is a revolutionary scientist, biotech entrepreneur, and industry disruptor who is redefining the way we think about health, longevity, and human performance. With over 100 peer-reviewed publications and dozens of patents, his groundbreaking discoveries in nitric oxide research have shattered conventional health myths, igniting a billion-dollar market and transforming countless lives. A former professor of molecular medicine, Dr. Bryan left academia to take on Big Pharma and misinformation head-on, delivering real, science-backed solutions directly to the public. Now, as a sought-after speaker and author of The Secret of Nitric Oxide: Bringing the Science to Life, he's on a relentless mission to arm people with the tools to reclaim their health, optimize performance, and defy aging.SHOW NOTES:0:39 Welcome to the podcast!1:48 Dr. Nathan Bryan's Bio2:29 Welcome him to the show!3:30 The purpose of Nitric Oxide in the human body5:11 What depletes our Nitric Oxide?8:27 Erectile dysfunction & Viagra13:12 Can NO override bad habits?14:41 Nitrate-rich foods17:06 Oral microbiome & blood pressure19:29 How nitric oxide affects sleep apnea & sleep-disordered breathing 21:52 Breathing while exercising23:41 Supporting the immune system with NO25:42 Testing levels with saliva strips28:36 Dosing nitric oxide31:08 Arginine & Citrulline supplements37:36 Pharmaceutical industry45:25 Heavy metals & adrenal tumors48:39 Dr. Nathan's morning routine53:19 Where to find him54:32 Thanks for tuning in!RESOURCES:Website: drnathansbryan.comN1O1 SupplementsIG: @drnathansbryanYouTubeSupport this podcast at — https://redcircle.com/biohacker-babes-podcast/donationsAdvertising Inquiries: https://redcircle.com/brands

Charles River scientist Nicole Hoekstra, herself a US Navy veteran, used her employer-supported sabbatical to help out local Oklahoma based nonprofit Inner Circle Mental Health, which focuses on aiding veterans and first responders who are struggling with their mental health. I am joined by Nicole and ICMH founder Kate Cooper to discuss what this service means to both of them, how we can support family who are reluctant to accept help, and how the COVID pandemic impacted the mental health of first responders. 

This episode's Community Champion Sponsor is Ossur. To learn more about their ‘Responsible for Tomorrow' Sustainability Campaign, and how you can get involved: CLICK HEREEpisode Overview: Growing a company from $46,000 to $30 million in six years doesn't happen by accident—it requires vision, grit, and the right team. Our next guest, Beth Lachance, is the CEO and founder of Global Medical Virtual Assistants, where she's revolutionizing administrative support for medical practices nationwide. With 16 years as an entrepreneur and over 22 years of healthcare leadership experience, she brings strategic vision and hands-on execution to building high-performing distributed teams. Driven by a passion for operational excellence and leveraging global talent, Beth shares how GMVA is transforming healthcare staffing through HIPAA-compliant virtual assistants from the Philippines. Join us to discover how her team is helping practices reclaim time, reduce costs, and refocus on patient care. Let's go!Episode Highlights:The Right Team Matters - Finding the right advisors and team members is critical, even when it means parting ways with early supporters.Leadership Evolves with Growth - Different business stages require different leaders; Beth is now bringing on a CFO as GMVA scales.$46K to $30M in Six Years - GMVA's explosive revenue growth demonstrates massive demand for virtual healthcare staffing.Reimagining Healthcare Work - GMVA transforms medical practices through remote administrative support, freeing providers to focus on patients.Tough Decisions Drive Success - Beth learned that moving on from trusted early team members, though painful, unlocks company potential.About our Guest: Beth Lachance is the CEO and founder of Global Medical Virtual Assistants (GMVA), whereshe drives sustainable growth and operational excellence for a company revolutionizingadministrative support for U.S. medical practices. With 16 years as an entrepreneurspecializing in real estate and over 22 years of corporate leadership in Surgical Device,Pharmaceutical, and Specialty Pharmacy industries, Beth blends strategic vision with hands-on execution to build high-performing teams and achieve long-term success.A former Division I gymnast on full scholarship at the University of Florida, Beth earned herBachelor of Science in Health Sciences, a testament to her discipline and goal-drivenleadership.Links Supporting This Episode: Global Medical Virtual Assistants Website: CLICK HEREBeth Lachance LinkedIn page: CLICK HEREGlobal Medical Virtual Assistants LinkedIn: CLICK HEREMike Biselli LinkedIn page: CLICK HEREMike Biselli Twitter page: CLICK HEREVisit our website: CLICK HERESubscribe to newsletter: CLICK HEREGuest nomination form:

Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopedics at Feinberg School of Medicine, joins Lisa Dent to discuss several pharmaceutical stories. And, as always, he answers questions from listeners.

Listen in as our expert panel explores the clinical challenges of veterinary pharmacology, discussing medications, supplements, and inactive ingredients that can be dangerous to pets. You'll hear practical dispensing and safety guidance, along with evidence-based strategies to help pharmacists protect animal patients from accidental exposure to human medications.Special guests:Alexandria Gochenauer, PharmD, DICVP, FSVHP, FACAStaff Pharmacist and Interim Pharmacy Manager, WalmartPresident-elect of the American College of Veterinary PharmacistsErica Wassack, PharmD, DICVP, FSVHP, FACVPAssociate Pharmacy OfficerPlumb's Veterinary Drugs, Instinct ScienceTina Wismer, DVM, MS, DABVT, DABT Senior DirectorASPCA Poison ControlNone of the speakers have anything to disclose. This podcast is an excerpt from one of TRC's monthly live CE webinars, the full webinar originally aired in September 2025.TRC Healthcare offers CE credit for this podcast. Log in to your Pharmacist's Letter, Pharmacy Technician's Letter,or Prescriber Insights account and look for the title of this podcast in the list of available CE courses.Claim CreditThe clinical resources mentioned during the podcast are part of a subscription to Pharmacist's Letter, Pharmacy Technician's Letter, and Prescriber Insights: FAQ: Med Considerations for Cats and DogsArticle: Don't Chase Your Tail With Pet RxsPodcast: Clinical Capsules - Avoiding Medication Mishaps with Pet PrescriptionsUse code mt1025 at checkout for 10% off a new or upgraded subscription.Send us a text*****

Chasing a C-level role? Today we explore what sorts of skills and broad experiences to gain in your career if you want to land a seat in the C-suite.My guest today is Tanya Graham, CIO icare.   In this episode, Tanya:Talks about her career journey from operations and manufacturing, through to consulting, tech and digital, healthcare, and strategic transformation How moving from UK to Australia provided fresh, varied experience and broadened her networking and industry opportunityHow transformation has underpinned every role Tanya has taken on throughout her career and drawn her to certain organisationsHow Tanya weighs up whether a new opportunity is aligned for herThe critical skills modern Exec Leaders need in their toolbeltGetting intentional about your careerTanya, on making good decisions for your career:"I have done a few decision making analyses when weighing up different career opportunities! There might be some non-negotiables for you such as learning opportunities; what the leadership team's like; where the organisation is heading; and what the mentorship's like [to help you make an aligned decision]." Tanya, on having broad experiences:"Executive leaders are leading the business, not just their function. You need to have a breadth of experience to work through the most challenging situations. This will also help you anticipate trends and avoid tunnel vision and also makes you more comfortable with ambiguity and change."  Links:Connect with Tanya Graham on LinkedinConnect with Rebecca Allen on LinkedinVisit the Illuminate website to learn more about standout Career & Leadership coaching for womenRate, Review, & Follow our Show on Apple Podcasts:Also, if you haven't done so already, follow the podcast. We air every week and I don't want you to miss out on a single broadcast. Follow now!About Tanya:Tanya Graham is the Group Executive Digital & Transformation at icare NSW where she leads the Strategy, Transformation and Technology teams, delivering the icare strategy through a focus on performance and care, uplifting and digitising experience, introducing new ways of working to increase responsiveness and speed to value, and driving the use of data, automation and AI to ensure better outcomes for the people of NSW. Having been in senior & executive roles for over twenty years, she has experience working with Board Directors, Executive teams and regulators, to drive transformational change across industries including Pharmaceutical & Healthcare, Utilities, Financial Services, Technology, Retail and Property, and Government. Tanya is a graduate of the Company Directors course, Australian Institute of Company Directors (GAICD), has an MBA from Macquarie Graduate School of Management (MGSM), and is a member of the Institute of Engineering & Technology (IET). About Rebecca:Rebecca Allen is a Career & Leadership Coach for corporate women, aspiring to senior levels of leadership. Over the last decade, Rebecca has helped women realise their potential at companies including Woolworths, ANZ, J.P. Morgan, PwC, Coca-Cola Amatil, Ministry of Defence, Frontier Sensing and AbbVie Medical Research through her Roadmap to Senior Leadership coaching programs. Connect with Rebecca

Subscribe to UnitedHealthcare's Community & State newsletter.Health Affairs' Jeff Byers welcomes Stacie Dusetzina of Vanderbilt University Medical Center and David Simon of the University of Connecticut back to the pod to the current state of drug prices, how proposed tariffs may impact the pharmaceutical industry, that Pfizer deal, what consumers can expect if tariffs are added to prescription drugs, what exactly TrumpRx is, and more.Become an Insider today to get access to our third trend report focusing on the influence of private equity in health care.Related Articles:Trump admin readies 'imminent' probe into other nations' drug pricing, raising new tariff threat: FT (FiercePharma)President Trump's Executive Orders On Prescription Drug Prices: What The Evidence Says (Health Affairs Forefront) Subscribe to UnitedHealthcare's Community & State newsletter.

Did you know that almost every medical study ignores female biology, and that's why most women's health advice doesn't actually work? Josh Trent welcomes Kayla Osterhoff, Neuropsychophysiologist and Women's Health Expert, to the Wellness + Wisdom Podcast, episode 777, to reveal why women's cycles make them a different person every single day, how hormones influence mood, energy, and creativity, and why syncing your life with your biological rhythm is the key to balance, vitality, and freedom. Learn More About Female Biology in Her Biorhythm Course Her Biorhythm™ is the only science-based women's health program designed around a woman's unique biology. Her Biorhythm is a personally-focused women's health program designed to help you master your energy, cognition, mood, and overall health by leveraging your feminine biological gifts. Using your unique biorhythm as a map, you will be guided into a place of balance, ease, and better health. The key is to shift efforts with the flow of your biology instead of against it. Choose your course Get 10% off with code JOSH In This Episode, Kayla Osterhoff Uncovers: [01:10] Women's Daily and Monthly Hormonal Changes Why women are a different person every single day. How hormones create physiological changes. Why women's hormonal cycles change across their life. Resources: Kayla Osterhoff Her Biorhythm Courses - 10% off with code JOSH [03:50] How Mental Health Affects Women's Health How our childhood experiences shape our general opinion of men and women. Why Kayla's mother struggles with mental illness. How women are affected more by mental illness than men. [07:00] Discovering A New Path for Women How Kayla found out her mother was addicted to pain medication. Why it was very difficult to find help for her mother to recover from addiction. How her mother's addiction led Kayla to change her major. Resources: link study (oxycotin)?? [10:50] Why There's Not Enough Research on Women Why women represent the largest gap in research. How women's constant physiological changes make it harder to get reliable research data. Why men's biological system works on a 24-hour system that repeats every day. How women's studies are more expensive because their data needs to be collected during 90 days. [15:45] Is All Research Inaccurate? Why we need to change how new studies are run. How most studies are not done properly and can't be applied to women. Why Kayla is reforming the research system to collect women's data correctly. [19:45] Why History Revolves Around Men Why the female physiology is the most complex biological system on the planet. How male naming rights started. The role of women in the age of enlightenment and the industrial age. How women first entered male-dominated industries during the First World War. Why the age of information is skewed to male bias. [28:55] The System Works Better for Men Why we don't need to remove the old system but rather create a more flexible system. How we bypass the gifts of our biological systems. Why we need to start co-creating together and support everyone based on their biological needs. How the current system works better for the male biological rhythm. Why the gift of women's biology is creativity. [36:15] Are Sex and Gender Not The Same Thing? Why society needs understanding, compassion, acceptance, and acknowledgment. What is creating gender dysphoria. Why Kayla believes sex and gender are two separate things. How gender and sex used to have one meaning, but they have different meanings in today's society. Why Josh believes that gender dysphoria is rooted in perversion. [45:50] Men and Women Are Created to Work Together Why the war between men and women is a product of societal conditioning. How the male and female gifts complement each other. Why we need both male and female leadership. How all of us come from the same source. [49:50] What's Blocking Human Evolution? How we're trying to make everyone across society the same. Why women are not biologically inconsistent. What's preventing us from evolution. [52:25] What Men Need to Know About Women How hormones create a complex biology in women. Why women's biology is changed based on the concentration of certain hormones. The importance of getting comfortable with constant changes as a woman. How the four phases of the menstrual cycle affect women. Resources: 748 If Talk Therapy Worked, You'd Feel Better: New MDMA Therapy Breakthrough | Mike Zeller [56:40] Updating The Educational System How Kayla teaches others about women's physiology. Why children should learn the phases of female biology at school. How the educational system needs to be udpated. [59:30] The Four Phases of the Menstrual Cycle The reason why both men and women like the ovulation phase. Why women feel their best and most productive when they're ovulating. How the first week of the menstrual cycle is a process of shedding. Why craving food and sugar in the menstrual phase is a sign of dysregulation. How women's intuition is heightened during their period. [01:07:10] The Follicular Phase How estrogen impacts the follicular phase. Why women have higher mental energy and better mood when their estrogen is higher. How women can get into estrogen dominance, which causes dysregulation. Why women reach their peak estrogen at the time of ovulation. How women can leverage the follicular phase for leadership and networking. [01:12:00] Why Women Burn Out More Than Men How the ovulatory phase sets the bar for women's standard. Why women experience burnout 200% more often than men. How Kayla's burnout helped her understand the cycle better. What led to her burning out her adrenals and sex hormones. Why she competed to prove herself and be the best in her subject matter. How her body rejected the lifestyle she was living. [01:17:40] Allow Women to Be Inconsistent Why Kayla is more effective and loved now that she's embraced her femininity. What makes people become grumpy when they get old. The importance of allowing women to be inconsistent based on their hormonal phase. [01:22:30] Understanding Luteal Phase Can Change The World Why the first week of the luteal phase is different than the second week. How progesterone changes women's physiology during the luteal phase. Why the female brain grows in the luteal phase. How women get greater resilience first, but the nervous system becomes more sensitive during luteal phase. [01:29:05] Mental Health Is Gender Specific Why most rat lab tests are done on male rats. How mental health and related drugs need to be addressed differently in women. Why the capacity to withstand traumatic situations is affected by the hormonal cycle. Resources: 345 Zach Bush MD: Humanity, Consciousness & COVID19 Parental olfactory experience influences behavior and neural structure in subsequent generations [01:35:30] How to Make Healing Fun Why nothing is really as serious as we think. How we can make healing fun. Why our childhood wounds impact our behavior. There is beauty in every phase of a woman's cycle. "Women are essentially four different people across the span of a month due to hormonal changes. But women are also different people every single day because the physiological shifts, the neurological shifts, and the hormonal shifts are happening little by little every day and constantly shifting physiological processes across the global biological systems." — Kayla Osterhoff Leave Wellness + Wisdom a Review on Apple Podcasts All Resources From This Episode Kayla Osterhoff Her Biorhythm Courses - 10% off with code JOSH 748 If Talk Therapy Worked, You'd Feel Better: New MDMA Therapy Breakthrough | Mike Zeller 345 Zach Bush MD: Humanity, Consciousness & COVID19 Parental olfactory experience influences behavior and neural structure in subsequent generations

What will healthcare look like a decade from now? Host Glenn Hunzinger is joined by Greg Rotz, Pharmaceutical and Life Sciences Advisory Leader and Thom Bales, Principal, Health Services Advisory Leader, as they dive into the future of health—one driven by smarter tech, empowered consumers, and breakthrough science. From reimagining chronic care to building new business models, discover the mindset, partnerships, and capabilities that will define the next era of healthcare.Discussion highlights:A trillion-dollar shift: who gains and who falls behindThe rise of the super consumer and personalized careWhy experience design will become core to life sciencesHow health orgs can prepare with “no regrets” strategic movesCollaborating across the ecosystem to drive faster, better, cheaper care Speakers:Glenn Hunzinger, US Health Industries Leader, PwCGreg Rotz, Pharmaceutical and Life Sciences Advisory Leader, PwCThom Bales, Health Services Advisory Leader, PwCLinked materials:From breaking point to breakthrough: the $1 trillion opportunity to reinvent healthcareFor more information, please visit us at: https://www.pwc.com/us/en/industries/health-industries/health-research-institute/next-in-health-podcast.html.

Ryan Cox from Microbial Solutions joins us to discuss the curious creatures living at the edges of life – from microbes pulled from the MIR space station to antibiotic resistant bacteria festering in shark mouths. Meet these and many more on this episode!

Join the fx Medicine by BioCeuticals ambassadors, Emma Sutherland, Lisa Costa-Bir and Mick Alexander, hosted by Dr Adrian Lopresti, face-to-face, for an intimate discussion. Hosted by Dr Adrian Lopresti, clinical psychologist and researcher, this panel will explore the key elements of optimal brain health - going beyond theory into practical insights you can apply in clinic straight away. Our ambassadors bring decades of front-line experience and will share their top clinical pearls on brain health from multiple, integrative perspectives: - Lisa Costa-Bir (naturopath, nutritionist & women's health expert) explores movement as “brain medicine” to slow cognitive decline, while referring to Dr Helena Popovic's work on "Adventure prevents dementia". - Mick Alexander (integrative pharmacist & naturopath) breaks down the gut-brain and HPA axis plus overlooked medication nutrient depletions. - Emma Sutherland (naturopath & women's health expert) discusses hormones, “meno brain” and her top therapeutics. Enjoy the recording which our live audience described as "not only informative but joyful to watch", very insightful information backed by studies, gave real life examples", and "clinically relevant and practical". Don't miss out on our first ever live panel discussion. Held in collaboration with @ATMS. Covered in this episode (01:57) Key elements of optimal brain health: An overview of what makes a healthy brain? (Dr Adrian Lopresti) (10:30) Adventure prevents dementia: Practical strategies to add to you toolkit - novel activities, grip strength, tongue exercises to increase brain size (Lisa Costa-Bir) (35:00) Pharmaceutical drugs & the impact to the gut-brain axis: The significant impacts and potential therapies to maintain the gut-brain connection (Mick Alexander) (58:20) Hormones & brain function: Optimise women's brain health in perimenopause and menopause (Emma Sutherland) DISCLAIMER: The information provided on fx Medicine by BioCeuticals is for educational and informational purposes only. The information provided on this site is not, nor is it intended to be, a substitute for professional advice or care. Please seek the advice of a qualified health care professional in the event something you have read here raises questions or concerns regarding your health.

Is there evidence that even light exercise can improve mental health and help treat severe mental illness? How easy is it to prove the effects? Are our ever more sedentary lifestyles putting us at risk? How easy is it to apply in the current mental health treatment system?In this episode we have the revealing research on the use of exercise and movement to treat mental health to get up to date on. This is the third episode out of three in this series on the theme of life-style medicine, the other two being on Sleep for mental health (Episode #72 with Roxanne Prichard) and on diet for mental health (Episode #70 with Felice Jacka), so please check those out as all 3 interrelate in term of mental health outcomes. In this episode though we get into the reasons why even a little movement has a radical effect on our mental health; that movement can be used in association with talky and drug therapies to effectively treat even serious mental health disturbances like schizophrenia; we also get into the huge host of improvements across the board when exercise is applied; the impressive bulk of clinical trials that have proved this in the last 15 years; and we hear about the faster than usual uptake of this data by international policy makers, and the difficulties of practically integrating these protocols into the mental health care system.Now fortunately for us, our guest today is one of the world's leading researchers in this field, mental health physiotherapist and Kings College London researcher, Brendon Stubbs. He is the co-author of over 800 highly cited scientific papers, and the book “Exercise-Based Interventions for Mental Illness: Physical Activity as Part of Clinical Treatment”. What we discuss:00:00 Intro06:40 Early attempts on the mental illness ward as a physio.09:28 The rise of life-style research into mental health in the early 2000s.12:00 Sedentary lifestyle issues.13:24 The benefits of being both therapist & researcher.15:50 Resistance to the word ‘exercise'.19:00 Rise in sedentary lifestyle correlates with rise in mental health issues and stress.23:45 Higher inflammation in sedentary populations.26:30 Endorphins are not the only reason it feels good.30:15 15% drop in depression risk.33:10 Muscle, heart and lung strength is a marker for lower depression risk.35:30 Even genetic predispositions to depression can be 25% less at risk.36:30 Equally successful to CBT therapy.38:30 Hippocampus size variations with just 10 mins of light movement.41:45 Sleep, diet & movement increase hippocampus size & reduce inflammation.42:30 Schizophrenia & Psychosis studies.46:00 Difficulty with continuity of exercise when patients return to society.49:15 The body likes routine & reduced friction.50:00 Limitations of randomised control trials on life style interventions.54:15 The faster than usual integration of this into the consensus. 56:30 Policy creation at national and world health level.58:00 Pharmaceutical funded researchers pushing back against these results. 59:00 Difficulty applying this for family doctors and mental health professionals.01:01:15 Socio-economic mental health risk and difficulty of access.01:03:00 The national health money saving motivation is hard to prove.01:05:00 Main tips for movement for mental health. References:‘Physical Activity and Incident Depression: A Meta-Analysis' paper, Felipe Shuch et al. ‘Strength training has antidepressant effects' paper, Fabricio Rossi et al.‘Physical activity offsets genetic risk for incident depression' paper, Karmel Choi et al.‘Exercise and internet-based cognitive–behavioural therapy for depression' paper, Mats Hallgren et al.‘Light-exercise-induced dopaminergic and noradrenergic stimulation in the dorsal hippocampus' paper, T. Hiragana et al.The Lancet Psychiatry Commission: a blueprint for protecting physical health in people with mental illness

EP. 233:  Grab my FREE 4 Part Video Series: GLP1s Uncovered: https://bit.ly/GLP1uncovered If you're a woman dealing with hair loss, this episode is for you. I share my personal journey with hair, from growing up with a hairstylist mom to navigating stress, life changes, and different phases of hair growth. Hair, skin, and nails are all reflections of what's happening inside your body, and I break down what can really cause thinning, breakage, and shedding. I also cover my thoughts on hair loss treatments, from nutrition and stress management to thyroid support, Minoxidil, PRP, red light, and supplements. Whether you're looking for answers or curious about how different treatments work, I walk you through the factors that matter most for healthy hair. Topics Discussed: → What causes hair loss in women? → How do stress and cortisol affect hair? → Can GLP1 medications cause hair loss? → What are the best treatments for thinning hair? → How does nutrition impact hair growth? Sponsored By: → Manukora | Head to manukora.com/DRTYNA to save up to 31% & $25 worth of free gifts in the Starter Kit, which comes with an MGO 850+ Manuka Honey jar. → Nutrisense | Head over to nutrisense.io/drtyna and use the code TYNA to save 33% on your Nutrisense Program. → BIOptimizers | For 15% off go to bioptimizers.com/drtyna and use promo code DRTYNA → LMNT: Get a free 8-count Sample Pack of LMNT's most popular drink mix flavors with any purchase at drinklmnt.com/drtyna.  → Timeline | Head to timeline.com/DRTYNA and get 20% off with code DRTYNA  → Vandy | Ready to give Vandy a try? Go to vandycrisps.com/TYNA and use code TYNA for 25% off your first order.  On This Episode We Cover: → 00:00:00 - Introduction → 00:03:35 - Hair, trauma, and their connection → 00:07:53 - The main causes of hair loss → 00:13:50 - GLP1s and hair loss → 00:21:38 - Clinicians and GLP1s → 00:26:48 - Supporting thyroid health → 00:29:21 - Nutrition, stress, and cortisol's impact → 00:39:14 - Hair breakage and nutrient deficiencies → 00:43:40 - Hormonal imbalance and hair health → 00:46:50 - Pharmaceutical side effects → 00:49:54 - High stress life events and shedding → 00:53:26 - Minoxidil: benefits and considerations → 00:57:55 - Hair washing habits and ketoconazole → 01:00:04 - PRP (platelet-rich plasma) treatments → 01:04:52 - Additional therapies and solutions → 01:08:51 - Extensions, styling, and hair health → 01:11:49 - Red light therapy and supplements → 01:13:28 - Bodybuilding, hormones, and hair Further Listening: → EP. 221 | The GLP-1 Microdosing Lie: It's NOT a Weight Loss Strategy | Solo → EP. 91: Thyroid Secrets Your Doctor Doesn't Know | Solo Episode → EP. 232 | The Truth About Tylenol And NSAIDs | Solo Disclaimer: Information provided in this podcast is for informational purposes only. This information is NOT intended as a substitute for the advice provided by your physician or other healthcare professional, or any information contained on or in any product. Do not use the information provided in this podcast for diagnosing or treating a health problem or disease, or prescribing medication or other treatment. Always speak with your physician or other healthcare professional before taking any medication or nutritional, herbal or other supplement, or using any treatment for a health problem. Information provided in this blog/podcast and the use of any products or services related to this podcast by you does not create a doctor-patient relationship between you and Dr. Tyna Moore. Information and statements regarding dietary supplements have not been evaluated by the Food and Drug Administration and are not intended to diagnose, treat, cure, or prevent ANY disease.

What would your life look like if you could erase the limiting beliefs that make you feel unworthy, unloved, or not enough? Josh Trent welcomes Shelly Lefkoe, Belief Eliminator Extraordinaire and Co-Founder of the Lefkoe Institute, to the Wellness + Wisdom Podcast, episode 774, to uncover how childhood beliefs shape our identity, why events are always neutral, how self-doubt is planted early in life, and the proven process for dissolving limiting beliefs so you can experience freedom, confidence, and truth beyond the mind.

Colton teams up with Coach T—aka Tania, a Montreal-based personal and professional development coach who works virtually with clients across Canada, the U.S., and Europe—for a real-talk session on burnout, identity, and the fear that keeps so many of us stuck. Whether you're a nurse questioning your path, clinging to that job title for self-worth, or just burnt out but too scared to pivot, Tanya breaks down how coaching helps you untangle the chaos and take actionable steps toward what you actually want. No judgment, no pressure—just clarity, accountability, and a reminder that it's okay to choose a new direction.>>You're More Than a Nurse—This Life Coach Helps You Reignite Your PurposeJump Ahead to Listen:[00:01:06] Personal and professional development. [00:04:46] Pursuing fulfillment over corporate success. [00:06:42] Sailing adventure and life change. [00:12:16] Overcoming fear in coaching. [00:14:34] Coaching duration and dynamics. [00:16:10] Nursing burnout and career change. [00:19:10] Fear of career change. [00:24:02] Identity crisis in nursing. [00:25:47] Identity tied to job titles. [00:28:00] Self-worth and professional identity. [00:31:05] Prioritizing joy in life. [00:34:28] Work addiction and self-worth. [00:38:08] Coaching services and discovery calls.Connect with Colton on social media:Instagram: @coltonalanlord, @nursedaddies, @club.nurseTikTok: @nursecoltonConnect with Tania on social media: Instagram: @coachtmtlFor more information, full transcript and videos visit Nurse.org/podcastJoin our newsletter at nurse.org/joinInstagram: @nurse_orgTikTok: @nurse.orgFacebook: @nurse.orgYouTube: Nurse.org

When Dalila Sabaredzovic's sons were diagnosed with an ultra-rare genetic condition, she faced more questions than answers. But through resilience, advocacy, and the power of collaboration, her family's story has become a beacon of hope in rare disease research. In this deeply moving episode of Sounds of Science, Dalila shares her journey from despair to discovery—and how a global village of scientists came together to pursue a personalized treatment that could change everything.Show NotesTaking a Customized and Collaborative Approach to Therapeutic DevelopmentDrug Discovery Services | Charles RiverASO Screening Services | Charles RiverRare Disease Research for Drug Development | Charles RiverTwo in Eight Billion | Eureka blog

In this episode, Suzanne Spradley and Chase Cannon discuss a September 2025 presidential announcement regarding tariffs on pharmaceutical products. Suzanne provides some background on the announcement and what it might mean for the U.S. and other countries. Suzanne and Chase explore the potential benefits and drawbacks of a new website relating to prescription drugs. Suzanne closes the podcast by outlining the potential impact on employer-sponsored group health plans and drug plans.

Dr. Sterling Elliott, clinical pharmacist at Northwestern Medicine and assistant professor of orthopedics at Feinberg School of Medicine, joins Lisa Dent to discuss several pharmaceutical stories. And, as always, he answers questions from listeners.

Scott Zari says investors can avoid the Trump administration's pharmaceutical tariffs by looking to companies that are already domestically manufacturing drugs and medicine like Eli Lilly (LLY). Compared to other drugmakers that have dipped into the weight-loss market, Scott says injectables will continue to be the primary use case saying pills haven't yet overtaken it. He looks at other drugmakers like Pfizer (PFE) and Novo Nordisk (NVO).======== Schwab Network ========Empowering every investor and trader, every market day.Subscribe to the Market Minute newsletter - https://schwabnetwork.com/subscribeDownload the iOS app - https://apps.apple.com/us/app/schwab-network/id1460719185Download the Amazon Fire Tv App - https://www.amazon.com/TD-Ameritrade-Network/dp/B07KRD76C7Watch on Sling - https://watch.sling.com/1/asset/191928615bd8d47686f94682aefaa007/watchWatch on Vizio - https://www.vizio.com/en/watchfreeplus-exploreWatch on DistroTV - https://www.distro.tv/live/schwab-network/Follow us on X – / schwabnetwork Follow us on Facebook – / schwabnetwork Follow us on LinkedIn - / schwab-network About Schwab Network - https://schwabnetwork.com/about

PHARMACEUTICAL RITUALS: THE MEDICINE WE WERE NEVER MEANT TO QUESTIONThey called it science.They called it progress.But somewhere along the way, healing became a ritual — and belief replaced truth.This episode dives into the sacred illusion of modern medicine — where profit masquerades as compassion, and compliance is the new faith. From the altar of Big Pharma to the priests in lab coats, we trace the hidden symbols, the revolving doors, and the unspoken oaths that turned medicine into mass hypnosis.Ask yourself…Who wrote the scriptures of “safe and effective”?Why is dissent treated as heresy?And what if the real experiment isn't in the lab — it's us?

Steve Forbes explains how Puerto Rico can once again become a pharmaceutical powerhouse and help achieve the much-needed goal of reshoring U.S. drug manufacturing.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Key Points Seadon experienced his first Grand mal seizure at age three, lasting over 20 minutes, with medical staff initially believing he would suffer brain damage from the prolonged episode.Medical professionals prescribed benzodiazepines which reduced seizure frequency and severity but required continuous dose increases as Seadon continued having seizures for four years.By age seven, Seadon was taking the maximum benzodiazepine dose equivalent to an 18-19 year old but still experiencing seizures, prompting consultation with alternative neurologists.Memory impairment was identified as a significant side effect of the benzodiazepine medication, causing Seadon to forget basic daily tasks and potentially creating permanent cognitive damage.Research into natural alternatives consistently pointed to cannabis as the only viable option, though specific dosing and cultivation information was extremely limited at the time.Pharmaceutical shortage crisis forced an immediate decision when Seadon's medication became unavailable, with Health Canada offering three replacement drugs including ones with suicide risk and irreversible liver damage.Cannabis treatment began with a one-to-one CBD-THC tincture obtained from a veteran's prescription, starting with low doses while simultaneously weaning off benzodiazepines.Seadon achieved complete seizure freedom for 11 years using a customized cannabis regimen of 20-to-1 CBD-THC ratio during daytime and 1-to-1 ratio at nighttime.Memory function significantly improved after transitioning from pharmaceuticals to cannabis, contradicting common misconceptions about cannabis effects on developing brains.Legal prescription acquisition took over 18 months due to reluctance from healthcare providers to treat pediatric patients, eventually obtained through a questionable cannabis clinic charging $2,000 annually.Medical establishment resistance continued even after successful treatment, with neurologists refusing prescription renewals despite 100% seizure control and excluding Seadon from cannabis epilepsy studies.Family doctor refused to write cannabis prescriptions despite supporting the treatment results, ultimately involving legal counsel when challenged about patient rights violations.EduCanNation nonprofit was founded in 2020 to standardize cannabis education and provide proper guidance to patients, addressing the lack of reliable information and support systems.Organization connects certified cannabis educators who are primarily former patients, aiming to share evidence-based knowledge and prevent others from experiencing similar healthcare navigation challenges. Visit our website: CannabisHealthRadio.comFind high-quality cannabis and CBD + get free consultations at MyFitLife.net/cannabishealthDiscover products and get expert advice from Swan ApothecaryFollow us on Facebook.Follow us on Instagram.Find us on Rumble.Keep your privacy! Buy NixT420 Odor Remover Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

100125 Scott Adams Show, Schumer Shutdown, Democrat Hypocrisy, Trump Pharmaceutical Price Reduction

US President Donald Trump has announced a new wave of tariffs, including a 100% levy on branded or patented drug imports from 1 October - unless a company is building a factory in the US. We hear from Germany's VFA association of pharmaceutical companies.And, the price of love - hundreds of alleged romance scammers are arrested as part of an international operation. The CEO of a dating app tells us how to protect users from scammers.Tattoos were once reserved for rockstars or sailors, but are now part of a mainstream industry predicted to be worth $6.5 billion by 2033. So what's behind this booming trade?You can contact us on WhatsApp or send us a voicenote: +44 330 678 3033.Presenter: Sarah Rogers Producer: Victoriya Holland Editor: Justin Bones

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”. Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. Hosted on Acast. See acast.com/privacy for more information.

Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”. Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account. Hosted on Acast. See acast.com/privacy for more information.

Exposing Big Food, Big Pharma, and the Path to True Health In this week's episode, Marcus, Melanie meet with Calley Means — entrepreneur, healthcare reform advocate, and co-founder of TrueMed. Calley has been making waves in the national conversation about health, nutrition, and the systems driving chronic disease. As a former consultant to some of the largest food and pharmaceutical companies in the world, Calley offers a rare insider's perspective on how financial incentives can prioritize profits over people. Now, through TrueMed, he's working to flip the script — helping Americans use tax-free health savings accounts to pay for food, exercise, wellness coaching, and other preventative health measures. Calley is also the co-author (with his sister) of the bestselling book Good Energy, which explores the connection between metabolism and health, and he's an investor in companies tackling metabolic health, mental health, and longevity. A graduate of Stanford University and Harvard Business School, Calley also co-founded Anomalie, a custom bridal brand later acquired by David's Bridal. In this powerful and eye-opening conversation, Calley shares: •How his insider view of Big Food and Big Pharma shaped his mission to reform healthcare •The shocking incentives that drive the chronic disease crisis in America •How TrueMed empowers people to use HSAs and FSAs for healthy living •The link between metabolism, mental health, and performance — and why it matters for every American •Why systemic change requires both personal responsibility and policy reform Whether you're a health professional, a parent trying to improve your family's nutrition, or simply curious about the future of healthcare, this episode will challenge assumptions and offer practical solutions. Don't miss this episode with Calley Means — a candid, informed, and inspiring discussion on how we can take back control of our health. In this episode you will hear: • [Marcus] We turned a vegan into a meat-eater. A vegetarian was working at our house and smelled [Mama Holly's Prime Rib] and said “What is that?” And I said that's prime rib and said “I'm a vegetarian.” I said “I don't know man. I think you might give this one a whirl.” (3:20) • Pharmaceutical is about 50% of TV advertising. (5:50) • The 2 ways you get researchers money is just research grants (that's their life blood) and direct bribes. (7:10)  • Anxiety was created as a sub-category of medicine in the 1970s, explicitly by pharmaceutical companies who had Valium to sell. (8:21) • If you can make obesity a national standard and tell people it's not you fault and jab them for a lifetime – that's a profitable patient. (18:33) • 25% of women are on some kind of psychiatric drugs, That produces reoccurring appointments and prescriptions. (20:01) • A doctor is a medical drug doctor. They're a drug prescriber. Who made that rule? That's not how it is in other countries. (22:51) • [Marcus] If you tell yourself your body is a racecar, or a fighter jet, or a monster truck, what kind of fuel are you putting in that sucker? (36:40) • If you can get seed oils, processed sugar and processed grains out of you house, that gets you about 80% there [the single most important thing a household could do.] • I think people should be more scared. I think we should have apps and blood tests and doctors telling people “You're not gonna make it through your life to meet your grandkids.” (41:57) • [Farmers] have low prices, high input costs, more weather challenges, trade issues that aren't their fault. They're taking it from all fronts. (59:05) • The system is built for drugs, not medicine right now. Drugs are profitable, healing is not profitable. Thriving is not profitable. (65:56) Support Calley:  Book --> https://a.co/d/8T7DaqJ Support TNQ   - IG: team_neverquit , marcusluttrell , melanieluttrell , huntero13   -  https://www.patreon.com/teamneverquit Sponsors:   - Navyfederal.org        - meetfabiric.com/TNQ   - masterclass.com/TNQ   - Prizepicks (TNQ)   - Dripdrop.com/TNQ   -  cargurus.com/TNQ    - armslist.com/TNQ    -  PXGapparel.com/TNQ   - bruntworkwear.com/TNQ    - Selectquote.com/TNQ    - Groundnews.com/TNQ    - shipsticks.com/TNQ    - strawberry.me/TNQ    - stopboxusa.com {TNQ}    - ghostbed.com/TNQ [TNQ]   -  kalshi.com/TNQ   -  joinbilt.com/TNQ    - Tonal.com [TNQ]   - greenlight.com/TNQ   - PDSDebt.com/TNQ   - drinkAG1.com/TNQ   - Shadyrays.com [TNQ]   - qualialife.com/TNQ [TNQ]   - Hims.com/TNQ   - Shopify.com/TNQ   - Aura.com/TNQ   - TAKELEAN.com [TNQ]   - usejoymode.com [TNQ]

Can depression be healed without antidepressants? Josh Trent welcomes Pixie Acia, Spiritual Wellness Coach, to the Wellness + Wisdom Podcast, episode 771, to share how nutraceuticals helped her transition off 15 years of antidepressants, why trauma shows up in our bodies until we face it, and how breathwork, community, and cycle-breaking practices can unlock healing far beyond pharmaceuticals. Nutraceuticals from Altrient (LivOn Labs) In order to repair the structural damage caused by a continual barrage of toxic substances and pathogens, your body requires a constant supply of phospholipids. Whilst humans can synthesise some phospholipid compounds, others are sourced from food. Phospholipids that are obtained from the diet are called ‘essential phospholipids'. The liposomes used in Altrient products are made from essential phospholipids that include a high percentage of Phosphatidylcholine (PC). These liposomes not only provide optimum protection and transport, but they also satisfy the body's need for PC, omega-6 fatty acids, and choline. Now Altrient has taken the power of LET out of the laboratory and put it into your hands. It's why Altrient products are so effective. High-performance nutrients delivering enhanced absorption! Try it for yourself In This Episode, Pixie Acia Uncovers: [01:10] Nutraceuticals: Natural + More Efficient than Anti-Depressants The role of nutraceuticals in treating depression. Why Pixie spent 15 years on depression medications. How liposomal applications help us absorb 80-90% of nutrients from a supplement. Why nutraceuticals provide clarity and allow us to feel our emotions more than antidepressants. How nutraceuticals affect both the brain and the gut. Why depression is a combination of trauma and imbalances in the brain. We can't heal from depression with just one practice. Resources: Pixie Acia LivOn Labs (Altrient) [07:30] Does a Vegan Diet Cause More Harm than Good? How a vegan diet ruined Pixie's health. Why she attached her identity to being vegan and stopped listening to her body. How she switched to a carnivore diet to feel better. Resources: The Effects of Vegan Diet on Fetus and Maternal Health [12:50] The Gift in Traumatic Experiences Why we care about what other people think about us based on evolution. How trauma took Pixie's innocence and childhood. Why tattooing her body was a trauma response. How she channelled her trauma to help others. Why Pixie learned to detach from her body when she was abused. How forgiveness can help us let go. [19:10] Healed People Heal People How healed people heal other people. Why Pixie believes she went through her trauma for a reason. How her traumatic experience has helped her help others move through their trauma. [22:30] The Healing Power of Breathwork How breathwork helps us connect with our body. Why breathwork allowed Pixie to free herself from her traumatic sexual past. How breathwork can open us to new dimensions. Why we can get downloads from breathwork sessions. What led her to change her name from Amber to Pixie. [29:30] Why Do You Chase Dopamine? How the body is always looking for safety. Why Pixie attracted the same type of men until she healed her wounds. How chasing dopamine is a trauma response. Why Pixie created challenges to keep people accountable for their growth and getting healthy dopamine. It takes 62 days to create a new habit. [37:10] Becoming A Cycle Breaker Why Pixie found it hard to dance because of her sexual trauma. How expressing her sexuality made her feel like she would be taken advantage of. What pushed her to break the cycle. Resources: Michael Edward Johnson's Latch Theory The Body Keeps The Score by Bessel van der Kolk [43:50] The Value of Community Why community is the new currency. How human connection will become more valuable. What it means to be a safe container for others. How people come up against their projections and beliefs when they go to a retreat. Why when you let people see us, we become more lovable. [49:35] The Catalyst for Change What happened and why it happened doesn't truly matter. Why what we don't express shows up as depression or disease. How doing our own healing helps other people heal. Leave Wellness + Wisdom a Review on Apple Podcasts All Resources From This Episode Pixie Acia LivOn Labs (Altrient) The Effects of Vegan Diet on Fetus and Maternal Health Michael Edward Johnson's Latch Theory The Body Keeps The Score by Bessel van der Kolk Power Quotes From Pixie Acia "What is repressed will eventually get expressed as depression or disease." — Pixie Acia "If you suffer from depression, you need nutraceuticals. They help not just build the foundational blocks in the brain, but also in the gut, affecting the serotonin and giving you the essential support that it needs to not be depressed." — Pixie Acia "Your nervous system is looking for familiar situations to identify whether it's safe or not. When we're used to repressing it, we aren't listening to the body to know if we're safe or not. And then we'll end up finding ourselves in similar situations again." — Pixie Acia  

In this episode, we take a critical look at the state of America's pharmaceutical supply chain with John Knox, the principal deputy Assistant Secretary for Preparedness and Responses at the Health and Human Services Department. Explore the recent innovations and executive orders aimed at revitalizing domestic drug manufacturing, including the potential for small-scale production of generic drugs. Next, we delve into the critical state of America's pharmaceutical industry with retired army colonel Vic Suarez, founder of Blue Zone Bioscience and Supply Chain Solutions. Vic shares his insights on the alarming dependency on foreign nations for essential medications and the urgent need for reform. Join us as we discuss innovative manufacturing technologies, the intersection of critical minerals and pharmaceuticals, and the future of on-demand medicine. Finally, we sit down with Congressman Rich McCormick, a Marine Corps veteran and doctor, to discuss crucial issues surrounding America's healthcare and defense systems. We delve into the implications of the pandemic on drug supply chains, the importance of domestic manufacturing, and the challenges faced in military procurement. Congressman McCormick shares insights on the Biden administration's handling of healthcare, the need for strategic independence, and the future of military supply systems. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Liberated Life Series | Episode 770 Join Josh Trent, host of the Wellness + Wisdom Podcast, as he reveals why he went from complete astrology skeptic to believer after one session with world-class Astrologer Debra Silverman. Debra's framework exposed the exact patterns sabotaging his love and business life for years, patterns that over half a million people have now discovered. If you've been dismissing astrology as "woo-woo," this episode will show you the science-backed framework that reads your soul like a map and reveals the blind spots that are quietly running your life.